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Abstract 
 
Noncommunicable diseases (NCDs) are commonly characterized by not being passed from 
one person to another, being of long duration and slow progression. Premature mortality due 
to NCD is of major concern in low and middle-income countries as well as in high-income 
countries like Switzerland. Cardiovascular disease (CVD), cancer and chronic respiratory 
disease account for most of the NCD deaths worldwide. Whereas age-standardized rates 
declined between 1980 and 2015, the absolute number of NCD death increased e.g. due to a 
growing and aging world population. NCDs have individual risk factors, but share also 
common ones, e.g. behavioral factors such as smoking, environmental factors such as ambient 
particulate matter pollution, and hereditary factors. These risk factors are targets of NCD 
prevention, which can be classified as behavioral or structural and as primary, secondary, or 
tertiary, depending on the stage of disease development they are implemented at. Lifestyle 
factors offer great potential for the prevention of NCDs. Smoking, physical activity, diet, 
alcohol intake, and body composition were shown to be associated with NCD incidence and 
mortality. About 29% of cancer deaths were attributable to smoking in high-income countries 
in 2001 as well as 4% to alcohol and 3% to overweight and obesity. By investigating lifestyle 
factors individually their combined prevalence and distribution in the population is not 
captured. Furthermore, the coincident occurrence of multiple NCD risk factors has to be 
considered as likely. Aiming at understanding the lifestyle health outcome association, it is of 
importance to assess the impact of lifestyle patterns rather than of individual factors only. In 
the first paper presented, the association between mortality and lifestyle patterns was 
investigated by building a lifestyle score based on the cancer prevention recommendations of 
the WCRF/AICR 2007. The lifestyle score was shown to be associated with all-cause and 
cancer mortality. The lifestyle pattern of heavy smokers and obese individuals - two 
populations already being at high risk for adverse health outcomes - was examined in the 
second paper. Compared to normal-weight never smokers, heavy smokers and obese 
individuals were more likely to have an unhealthy lifestyle in general, whereby the 
association was stronger in heavy smokers. Working on this paper, the methodological issues 
arose how to deal with continuous outcome variables such as BMI in the analysis. This led to 
the third paper, in which we propose the novel approach of continuous logistic outcome 
regression to improve statistical analysis by using post hoc instead of ad hoc categorization of 
the outcome. This has the two main advantages of preventing information loss and improving 
between-study comparability. The association between BMI and smoking was used as a case 
study. Another risk factor for NCD that was studied intensively is personality. However, 
evidence for an association is rather limited because of mixed results. The majority of studies 
focused on CVD and although an association was shown for e.g. hostility, the effect size was 
too small to identify public health relevance. The early findings, that type A personality is 
associated with CVD events were not supported by subsequent studies. For cancer, there is no 
evidence for an association with personality. Using different definitions and measurement 
instruments across studies to capture personality might have led to these mixed results, as 
well as not taking into account the individual components of the applied instrument. Targeting 
this latter aspect, we showed in the fourth paper that the components of the type A 
measurement instrument Bortner Scale, i.e. speed and competitiveness, were associated with 
mortality, but not the entire Bortner Scale. To conclude, lifestyle patterns were shown to be of 
major importance for the prevention of NCDs. For personality the evidence is limited, 
however a more sophisticated analysis of applied instruments might enhance the 
understanding of its association with NCDs. 
Zusammenfassung 
 
Nichtübertragbare Krankheiten (NCD) sind im Allgemeinen dadurch gekennzeichnet, dass sie 
nicht von Person zu Person übertragen werden und chronisch verlaufen. In Ländern mit hohen 
Einkommen wie der Schweiz, aber auch in Ländern mit niedrigen bzw. mittleren Einkommen, 
sind NCDs von grösster Public Health Relevanz. Kardiovaskuläre Erkrankungen (CVD), 
Krebs und chronische Atemwegserkrankung verursachen die meisten NCD Todesfälle 
weltweit. Während der altersstandardisierter Anteil der NCDs zwischen 1980 und 2015 
zurückgegangen ist, hat die Anzahl der Fälle durch eine wachsende und alternde 
Weltbevölkerung zugenommen. NCDs haben neben individuellen Risikofaktoren auch 
gemeinsame, z.B. Verhaltensweisen wie das Rauchen, Umweltbelastungen wie der Feinstaub, 
und genetische Veranlagungen. Die Prävention  spielt bei der Reduzierung der Krankheitslast 
von NCDs eine wesentliche Rolle. Es wird dabei zwischen Verhaltens- und 
Verhältnisprävention unterschieden. Des Weiteren setzen die Massnahmen der Prävention bei 
verschiedenen Stufen des Krankheitsprozesses an, wonach primär, sekundär und tertiär 
Präventionen unterschieden werden. Lebensstil bietet ein grosses Potential für die Prävention 
von NCDs. Für Rauchen, körperlich Bewegung, Ernährung, Alkoholkonsum und 
Körperzusammensetzung wurde ein Zusammenhang mit der Inzidenz und Mortalität von 
NCDs gezeigt. In Ländern mit einem hohen Einkommen wurden 2001 etwa 24% der 
Krebstodesfälle dem Rauchen zugeschrieben, dem Alkohol 4% und dem Übergewicht 
einschliesslich der Adipositas 3%. Einzelne Lebensstilfaktoren zu untersuchen vernachlässigt 
jedoch, dass Risikofaktoren kombiniert auftreten und somit das tatsächliche Risiko für NCD 
nicht geschätzt wird. Um die Beziehung zwischen Lebensstil und Gesundheit zu verstehen ist 
es wichtig, ebenso den Einfluss von Lebensstilmustern zu untersuchen und nicht nur den von 
einzelnen Risikofaktoren. Im ersten Paper der vorliegenden Arbeit wurde die Assoziation 
zwischen Mortalität und Lebensstilmustern anhand eines Lebensstil Scores untersucht, 
welcher basierend auf den Empfehlungen zur Krebsprävention des WCRF/AICR gebildet 
wurde. Es hat sich gezeigt, dass dieser Lebensstil Score mit Sterblichkeit insgesamt und 
Krebssterblichkeit assoziiert war. Die Lebensstilmuster von starken Rauchern und Adipösen - 
zwei Populationen die bereits ein erhöhtes gesundheitliches Risiko durch den entsprechenden 
Risikofaktor haben – wurden im zweiten Paper untersucht. Verglichen mit normalgewichtigen 
Nichtrauchern neigten starke Raucher und Adipöse zu einem insgesamt ungesünderen 
Lebensstil, wobei die Assoziation für starke Raucher stärker war. Bei der Erstellung dieses 
Papers kam die Frage auf, wie kontinuierliche abhängige Variablen (z.B. BMI) ausgewertet 
werden sollen. Diese Fragestellung führte zum dritten Paper. In diesem wurde der neue 
Ansatz der continuous outcome logistic regression vorgestellt und empirisch evaluiert. Bei 
diesem Ansatz wird die abhängige Variable nach der statistischen Analyse kategorisiert und 
nicht, wie derzeit gängige epidemiologische Praxis, vor der Analyse. Dies hat zwei 
wesentliche Vorteile, zum einen wird ein Informationsverlust durch die vorzunehmende 
Kategorisierung verhindert und zum anderen wird die Vergleichbarkeit zwischen Studien 
verbessert, indem auch Studien mit unterschiedlicher Kategorisierung der abhängigen 
Variable verglichen werden können. Die Assoziation zwischen BMI und Rauchen wurde 
hierfür als Fallstudie verwendet. Ein weiterer NCD Risikofaktor der intensiv untersucht 
wurde ist Persönlichkeit. Die meisten Studien zum Einfluss von Persönlichkeit auf NCD 
wurden zu CVD durchgeführt. Die Evidenz für eine Assoziation ist jedoch limitiert durch sich 
widersprechende Studienergebnisse. Beispielsweise wurde die Rolle von Feindseligkeit 
untersucht, hierbei konnte ein Zusammenhang gezeigt werden. Allerdings war dieser zu 
gering, um Public Health Relevanz zu erreichen. Des Weiteren hatten Ergebnisse früherer 
Studien zu CVD und Typ A Persönlichkeit eine Assoziation gezeigt, allerdings konnte diese 
durch spätere Studien nicht bestätigt werden. Für Krebs ist keine Evidenz für einen 
Zusammenhang mit Persönlichkeit vorhanden. Mögliche Erklärungen für diese sich 
widersprechenden Ergebnisse bzw. Nullergebnisse sind das Verwenden von unterschiedlichen 
Messinstrumenten und deren Analyse nach Gesamtskala. Um letzteren Aspekt genauer zu 
untersuchen, wurde im vierten Paper die Bortner Skala, ein Instrument zur Erfassung von Typ 
A Persönlichkeit, gesamt sowie nach ihren Subskalen Wettbewerbsfähigkeit und 
Geschwindigkeit untersucht. Dabei hat sich gezeigt, dass die Bortner Skala gesamt nicht mit 
Mortalität assoziiert war, aber ihre Subskalen. Zusammenfassend hat sich gezeigt, dass das 
Betrachten von Lebensstilmustern äusserst wichtig zur erfolgreichen Prävention von NCDs 
ist. Hingegen ist die Rolle von Persönlichkeit in der NCD Prävention noch unzureichend 
untersucht, aber die Anwendung von genaueren Analysen zur Auswertung der angewendeten 
Messinstrumente kann zukünftig dazu beitragen ein besseres Verständnis zu gewinnen. 
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Introduction 
 
 
 
Public health relevance of cancer and other noncommunicable diseases 
Noncommunicable diseases (NCDs) are commonly characterized by not being passed from 
one person to another, being of long duration and slow progression (1). NCD were estimated 
to account for 71.3% of deaths worldwide (39. 8 million) in 2015. Communicable, maternal, 
neonatal, and nutritional diseases (20.2% deaths, 11.3 million) were in second and injuries 
(8.5%, 4.7 million) in third place. The absolute number of NCD deaths increased since 2005 
by 14.3%, but age-standardized rates declined in the same time period from 719.1 to 624.7 
per 100 000 (2). This corresponds to 21 062.4 per 100 000 disability adjusted life years due to 
NCD in 2015 (3). NCD are not only of major concern in high-income countries, about 80% of 
premature deaths due to NCD occur in low and middle-income countries (1). NCD gained 
public health relevance in the past, because of an aging world population and decreasing rates 
of communicable, maternal, neonatal, and nutritional diseases (2). Globally, the life 
expectancy increased between 1980 and 2015 from 59.6 years in males and 63.7 years in 
females to 69.0 years and 74.5, respectively. The decrease in the rate of communicable, 
maternal, neonatal, and nutritional diseases was estimated to be 19.7% (absolute) and 29.6% 
(age-standardized) (2). 
Cardiovascular disease (CVD), cancer, and chronic respiratory diseases account for most of 
NCD deaths (17.9 million, 8.8, 3.8) (2). The leading cause of death worldwide is CVD (4). 
For both CVD and cancer the absolute number of deaths increased, but the age-standardized 
rates declined in accordance with the overall NCD trend (2).  
Deaths contributing to CVD mortality rose from 2005 to 2015 by 12.5%, given a decreasing 
age-standardized rate of 15.6%. The development was similar for ischemic heart disease 
(IHD) and stroke as they accounted for 85.1% of all CVD deaths in 2015. Deaths due to IHD 
rose by 16.6% since 2005. Age-standardized rates declined for both stroke (21.0%) and IHD 
(12.8%) (2). Between 2005 and 2015, the absolute number of cases increased strongest in 
cancer mortality (17.0%); at the same time the age-standardized rate decreased by 10.0%. 
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Tracheal, lung, and bronchus were the leading cancer types with regard to mortality (absolute 
number and age-standardized rates). Their number increased until 2015 by more than 20%; a 
development that can also be observed for colon, rectum, malignant skin melanoma, 
pancreatic, prostate, breast, and ovarian cancer. Strongest declines in death rates were 
observed for esophageal cancer (26.8%) and Hodgkin`s lymphoma (23.9%) (2).  
The same pattern of age-standardized rates as for CVD was reported for the two leading 
chronic respiratory diseases, i.e. chronic obstructive pulmonary disease (COPD, 22.9%) and 
asthma (31.3%). Whereas their absolute numbers did not changed considerably between 2005 
and 2015 (2). 
In Switzerland, a high-income country, NCD were estimated to account for 91% of deaths in 
2014. Cardiovascular diseases contributed 35%, cancers 27%, and respiratory diseases 4% to 
total deaths. Corresponding age-standardized rates were decreasing over the past decade, 
especially in CVD and cancer. The probability of dying premature, i.e. between 30 and 70 
years of age, was about 9% (5,6). In Switzerland 2013, the age-standardized mortality rates of 
IHD, stroke, lung cancer and respiratory diseases were lower than the European average (7). 
 
Causes of noncommunicable diseases 
NCDs have multiple modifiable risk factors (8). Cancer, CVD and chronic respiratory disease 
have individual risk factors, but share also common ones. These are for example, behavioral 
factors like smoking, or environmental factors like ambient particulate matter pollution and 
household air pollution from solid fuels, as well as hereditary factors (4,8–11). The role of 
chance in the development of cancer is also discussed, based on the notion that each stem cell 
division induces the risk of random mutations, which may lead to epigenetic changes 
(10,12,13). 
 
Terminology of prevention 
The World Health Organization (WHO) defines health as “a state of complete physical, 
mental and social well-being and not merely the absence of disease or infirmity” (14). Hence, 
“the highest attainable standard of health is one of the fundamental rights of every human 
being”. The disciplines health promotion, public health and medicine are targeting health, but 
indeed rely on different concepts of health, which are complementary (15). Health promotion 
is focusing on resources that keep individuals healthy using the salutogenic approach. Public 
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Health pursues to promote health as well, but geared towards populations by applying 
organized community efforts (15). Medicine aims to recover health after disease occurred, i.e. 
to cure disease or reduce symptoms to prolong a high quality of life. These disciplines share 
the concept of prevention, according to their respective focus. Prevention has the objective to 
avert the development of disease and preservation of the current health status, respectively 
(16). Primary, secondary and tertiary prevention measures are differentiated, depending on at 
which stage of disease development the measure is implemented (17). Primary prevention is 
applied in healthy individuals to protect them from disease development and manifestation of 
clinical symptoms. This is achieved by reducing risks in general, either on a population or 
individual level, e.g. by vaccination or provision of healthy meals in schools or workplace 
health promotion. Secondary prevention comprises the early detection of disease, taking into 
account known risk factors, i.e. screening of risk populations. Measures of secondary 
prevention are for example the screening for breast cancer, newborn screening and health 
check-ups by the general practitioner. Tertiary prevention starts when disease is diagnosed 
and targets at the prevention of the chronification and secondary disease. Examples of tertiary 
prevention are chronic disease management programs, care of cancer survivors, and 
rehabilitation (15–17). Another dimension of classifying preventive measures is the 
characteristic whether they are behavioral or structural. Behavioral measures aim to change 
the behavior of individuals or groups, whereas structural measures target the change of 
structures by the influence of other fields, which are not directly related to the health sector, 
e.g. city planning, public transportation and tax system (16,17).  
 
Chances and challenges in the prevention of noncommunicable diseases 
The reduction of the overall lung cancer incidence in western countries like the United States, 
Germany, and Switzerland is a successful example of NCD prevention (18). Established 
smoking control strategies, including campaigns, smoking bans, high taxes for tobacco 
products, and consulting of patients by general practitioners seem to be effective. 
Nevertheless, these efforts have to be intensified. Although the overall lung cancer incidence 
is decreasing, the incidence in women is increasing in respective countries (18). Vaccines 
were also shown to be highly effective to reduce liver cancer caused by Hepatitis B (19,20) 
and cervical cancer caused by HPV (21). One of the most prominent examples for successful 
CVD prevention is the North Karelia Project started in 1972 (22). A comprehensive 
community-based intervention was applied, involving multiple players like health services, 
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NGO's, industry, media and public policy. Within 40 years, in the 35- to 64-year-old male 
population the age-adjusted coronary heart disease mortality was reduced by 84% (22). 
The prevention of NCD offers the chance to reduce the burden of disease in the population 
considerably. The decline in most age-standardized NCD death rates is due to a reduction of 
known risk factors in the population and improvements in early detection and therapy (2). 
Especially for CVD, significant biomarkers such as hypertension (23) were identified to allow 
for the development of chemopreventive agents targeting the treatment of early disease (24). 
For cancer the treatment of early stages is particularly important to increase the chance of 
cure or prolonged and high-quality life. So far, this is much more difficult to realize for 
cancer, than for CVD (24). Most cancers are detected and treated too late (9). A lot of effort 
has been put into the cure of advanced disease, rather than early disease prevention and health 
promotion (24). The broader application of chemoprevention in the field of cancer is a matter 
of ongoing research (25,26). 
In general, it remains a challenging task to implement effective measures for the prevention of 
NCDs (24,27,28). Therefore, it is required that capacity building in public health and the 
translation of scientific findings into practice, i.e. evidence-based public health, is encouraged 
(29). The United Nations has drawn the attention of governmental leaders to NCDs 
worldwide. In 2013, the 66th General Assembly of the UN adopted a declaration, which 
requests the international community and its member states to further intensify their efforts in 
the prevention and control of NCDs (30). The WHO released a Global status as well as 
European progress report (31,32) and based on that a Global Action Plan in 2014 (33). For the 
European Region an Action Plan was already set in 2011 (34). Since 2017, in Switzerland a 
national NCD strategy has been implemented (6). 
 
Lifestyle factors and their potential for prevention of noncommunicable diseases 
Lifestyle factors offer great potential for the prevention of NCDs (35). Smoking, physical 
activity, diet, alcohol intake as well as body composition, most often measured using the 
Body Mass Index (BMI), are associated with NCDs (36–38). Ford et al. showed that the risk 
for all-cause mortality was reduced due to non-smoking by 56%, physical activity by 47%, 
and healthy diet by 26% (37).  
For cancer, it was shown that the importance of risk factors differed between high and low-
and-middle income countries (9). In high-income countries such as Switzerland, smoking, 
alcohol, overweight and obesity are the most important lifestyle risk factors. It was estimated 
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that in 2001 about 29% of cancer deaths in high-income countries were attributable to 
smoking as well as 4% to alcohol and 3% to overweight and obesity. The leading risk factors 
in low-and-middle income countries were smoking and alcohol as well, but also low fruit and 
vegetable consumption. In low-and-middle income countries 18% of cancer deaths are 
attributable to smoking, 4% to alcohol and 6% to low fruit and vegetable consumption (9). 
The traditional risk factors for CVD worldwide are hypertension, physical inactivity, high 
BMI, smoking as well as diabetes. In Eastern Europe, hazardous alcohol consumption is 
additionally of major importance (4). In an US sample from 1996-1998, the population 
attributable fraction was estimated to be 25% for hypertension, 17% for diabetes, 6% for 
obesity, 13% for smoking, and 9% for hypercholesterolemia (39). Except for the latter, the 
population attributable fraction (PAF) was shown to be rather stable over time. The PAF for 
hypercholesterolemia was reduced by 50% since 1987-1989. For COPD and asthma, two 
major chronic respiratory diseases, smoking as well as underweight and obesity are important 
lifestyle risk factors (40,41). It was shown that smoking is the major risk factor for COPD, but 
the estimated PAF based on cohort study data vary rather widely between 39.6% and 76.2% 
(42). 
 
Prevalence of lifestyle risk factors 
The prevalence of lifestyle risk factors in adults varies by region. For example, in countries 
such as Armenia, Russia and Indonesia the smoking prevalence exceeded more than 50% in 
men in 2012. On the other hand in Antigua and Barbuda, Dominica and Ethiopia the smoking 
prevalence in men was less than 10% (43). In Switzerland the prevalence was estimated for 
2012 to be 32% in men and 24% in women (44). Between 1980 and 2012, the global age-
standardized prevalence of smoking decreased from 41.2% to 31.1% in men and from 10.6% 
to 6.2% in women (43), but due to world population growth the absolute number of smokers 
increased (43). Non-smoking is strongly recommended (45), and it is important to combine 
cessation programs with weight control intervention to maximize induced health benefits 
(46). 
Harmful use and alcohol dependency were estimated to be prevalent in 1.8% and 2.3% of the 
world population, respectively (47). In the WHO European Region, their prevalence was 
highest in Russia (3.5%) and the Ukraine (4.0%). In these countries the most risky drinking 
patterns were observed. For alcohol use and related harms, it was observed that the difference 
between men and women regarding prevalence was decreasing (48). Men born in the early 
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1900 were 3.6 times more likely to experience alcohol-related harms than women. In birth 
cohorts of the late 1990 the corresponding risk was reduced to 1.3 in men compared to 
women (48). In Switzerland 2012, 14% of the population shows an alcohol consumption that 
induces health risks, either through chronic-high alcohol consumption (5%) or binge drinking 
(11%) (44). The recommendations for alcohol consumption differ by NCD. To prevent cancer 
alcohol abstinence is recommended (45). The recommendation on low-risk drinking differs by 
country (49). If alcohol is consumed, the American Heart Association recommends limiting 
the daily average of one to two drinks for men and one drink per day for women(50). One 
drink for example corresponds for example to 12 oz. beer (50). 
Between 1980 and 2013, the combined global prevalence of overweight and obesity increased 
from 28.8% to 36.9% in men and from 29.8% to 38.0% in women (51). In both, developed 
and developing countries the prevalence has increased, but differs by sex. In developed 
countries overweight and obesity were more prevalent in men, whereas in developing 
countries this was the case for women. In 2013, obesity prevalence exceeded 50% for men in 
Tonga and for women e.g. in Kuwait and Kiribati (51). In Switzerland 2014/15, the 
prevalence of overweight was estimated to be 41.6% in men and 19.6% in women; the 
prevalence of obesity was 13.9% in men and 11.6% in women (52). The recommendation on 
healthy weight is staying in a normal-weight range (45), i.e. having a BMI between ≥18.5 and 
<25 (53). 
Global estimates on general dietary behavior and low fruit and vegetable consumption in 
particular are rather rare. Hall et al. estimated that the prevalence of low fruit and vegetable 
consumption was 78.0%, using a data set including mainly low- and middle-income countries 
(2002-2003) (54). The prevalence was estimated to be lowest in Ghana (37.3%) and highest in 
Pakistan (99.3%) (54). For Switzerland low fruit and vegetable consumption was prevalent in 
87% of the population, nevertheless only 13% did not include fruits and vegetables in their 
daily routine (2014-2015) (55). Low fruit and vegetable consumption is defined as not 
adhering to the “5 a day” recommendation of the WHO, which targets the consumption of 
400g of fruit and/or vegetables (56). The WCRF released further recommendations on diet, 
e.g. limit the consumption of energy-dense foods and red meat, avoid processed meat and eat 
mostly foods of plat origin (45). 
The WHO estimated that 23% of the world population was physically inactive in 2010 (31). 
The prevalence was higher in women (27%) than in men (20%). Furthermore, it was shown 
that physical inactivity was more prevalent in high-income countries (33%), compared to low-
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income countries (17%). The highest prevalence was observed for the WHO Eastern 
Mediterranean Region (31%) and Region of the Americas (32%). The WHO defines physical 
inactivity as having less than 150 minutes of moderate-intensity physical activity per week, or 
equivalent (31). In Switzerland 2012, 27.5% of the population was physically inactive and 
consistent with the world population more women (30.9%) were inactive than men (24.1%) 
(57). These estimates are based on the Swiss recommendation on physical activity, which 
differs from the WHO recommendation by recommending 2.5 hours per week of moderate 
intensity or 1.25 hours per week of vigorous intensity to be physically active (57). 
 
Lifestyle risk factors and their combined impact: from single lifestyle factors to lifestyle 
patterns 
Investigating lifestyle risk factors individually, does not display their combined prevalence, 
distribution and impact on the population. But the coincident occurrence of multiple lifestyle 
risk factors for NCDs is likely (58–60). Reporting of multiple risk factors was shown to be 
associated with low educational level and health deterioration as well as having a chronic 
disease (58–61). The strongest association between lifestyle factors was shown for smoking 
and alcohol intake (59). De Vries et al. identified three clusters, i.e. the healthy, the unhealthy, 
and the poor nutrition cluster (61). Hence, lifestyle risk factors act synergistically in the 
development of NCD (4,11,35,38,62–64). To better understand the lifestyle-health outcome 
association, it is of importance to assess the impact of lifestyle patterns rather than of 
individual lifestyle factors only. 
Several studies investigated the association between a combination of lifestyle risk factors, 
i.e. lifestyle patterns, and different health outcomes. Loef et al. performed a meta-analysis 
based on 21 studies to investigate the combined effect of healthy lifestyle factors on all-cause 
mortality (65). Their results showed a decrease in the hazard of all-cause mortality 
proportional to the number of protective factors. The combined prevalence of 4 out of 5 
healthy lifestyles, i.e. normal-weight, low alcohol consumption, non-smoking, healthy diet, 
and sufficient physical activity, led to a reduction by 66% in all-cause mortality (65). These 
findings were further strengthened by subsequent studies (37,66–68), taking into account 
different populations, e.g. elderly (66) and Asian (67,68). Adherences to national 
recommendations on healthy lifestyle have been linked to reduced mortality (62,69). For 
cancer incidence and mortality, a protective association with healthy lifestyle was shown as 
well (62,70–75). Dartois et al. estimated that complying to common recommendations on 
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smoking, BMI, alcohol intake, fruit and vegetable consumption, and physical activity can 
prevent 6.3% of total cancers and 47.5% of lung cancers (70). To estimate the influence of 
healthy lifestyle on cancer besides smoking, several studies focused on the combined impact 
of the other mentioned lifestyle factors (71,72,74,75). Hereto, Romaguera et al. showed that 
adherence to the WCRF/AICR recommendations was associated with reduced risk of cancer, 
i.e. comparing participants with the highest level of adherence with those having the lowest 
led to 0.84 HR (95% CI 0.72, 0.99) in men and 0.81 (0.72, 0.91) in women (72). Similar 
protective associations have been observed for healthy lifestyle and CVD incidence as well as 
mortality (62,69,76–78). Carlsson et al. showed that having a healthy lifestyle, i.e. combined 
non-smoking, low alcohol intake, moderate physical activity at least once a week and a 
healthy diet was associated with reduced CVD incidence; independent of BMI (79). Mitchell 
et al. investigated the association between lifestyle pattern and CVD mortality (78). They 
found that a combination of at least 2 of the following lifestyle factors decreased the risk of 
CVD mortality (0.67 HR (95% CI 0.49,0.91): cardiorespiratory fitness, normal BMI, 
physically activity and non-smoking (78). Using the cancer prevention recommendations of 
the WCRF/AICR (45) and therefore not including the effect of smoking on CVD incidence or 
mortality showed also a protective association with healthy lifestyle factors (69).  
 
Personality traits and their potential for prevention of noncommunicable diseases 
The association between personality traits and mortality as well as NCD incidence has been 
widely studied. However, evidence for an association is rather limited. Studies investigated 
the association for different concepts of personality, e.g. individual traits, big five 
(extraversion, neuroticism, agreeableness, conscientiousness, and openness to experience 
(80)), type A (an individual’s behavior is characterized by ambitiousness, competitiveness, 
easily aroused hostility, impatience and an exaggerated sense of time urgency (81)) and type 
D (an individual’s behavior is characterized by the general tendency towards emotional 
distress characterized by high scores on social inhibition and negative affectivity traits (82)). 
For total mortality, only low conscientiousness was shown to be a risk factor across studies 
(83,84). Nabi et al. additionally observed an association with neurotic hostility (85). Other 
personality traits such as extraversion, neuroticism or dominance as well as type D and A 
personality were not associated with total mortality (86–90). The vast majority of studies on 
personality and its associations with health outcomes focused on CVD incidence and 
mortality. These studies showed the relevance of different concepts of personality. Individual 
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personality traits have been linked to CVD outcomes like anger and hostility (83,91–94), 
openness (95), and neuroticism (88). Nonetheless, there is also contradicting evidence (92). 
For example, Batty et al. did not confirm an association of extraversion or neuroticism with 
mortality (87). A meta-analysis observed an association with hostility, but the estimated effect 
size was very small and they concluded that it does not raises public health relevance (94). 
Jokela et al. investigated the association between personality traits by the main cardiac and 
cerebral disease outcomes (96). They showed that the risk for stroke and not coronary heart 
disease mortality was increased in individuals with higher extraversion. For high neuroticism 
the findings were opposite. High conscientiousness was associated with lower risk of 
mortality in both of the outcomes (96). Type A personality was first linked to CVD outcomes 
in the 1970s (97–100). However, subsequent studies did not confirm the indicated association 
(94,101–105). Gallacher et al. conclude in their study on incidence CVD events and type A 
personality that one can predict when an event will occur rather than whether it will occur 
(106). As an explanation, they suggest that type A personality increases the risk of being 
exposed to potential triggers, rather than affecting the process of atherosclerosis (106). In 
meta-analyses type D personality was shown to be relevant for the prognosis in CVD patients 
(107), although the estimated effect was declining over time (108). Kupper et al. concluded 
that type D personality was associated with an increased risk of cardiac events in coronary 
artery disease patients, but not with non-cardiac mortality or with events in individuals aged 
≥70 years (82). No significant association was observed between type D personality and 
coronary heart disease incidence (109). For cancer the evidence is much weaker, most studies 
did not show an association. Neither for the personality traits of the big five (87,88,110,111), 
nor for type A personality (112). Ranchor et al. summarized the existing evidence on cancer 
and personality by stating if an association exists at all, one can be confident that the overall 
effect size is much too small to have clinical and public health relevance (113). The same 
applies for respiratory diseases (87,88). 
Chapman et al. investigated the role of socioeconomic status and lifestyle factors in the 
association between personality and all-cause mortality (114). They showed modest 
associations between socioeconomic status (SES) and the big 5. Personality explained about 
20% of the SES gradient in all-cause mortality, while SES explained 8% of personality-
induced risk. Furthermore, they found that lifestyle factors explained the SES and personality 
induced risk; besides remaining residual risk (114). Several studies support this finding by 
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showing that personality and lifestyle risk factors are associated, e.g. physical activity 
(115,116), smoking (80,117), and diet (118–120). 
In conclusion, modifiable factors such as lifestyle are important targets of preventive 
measures to reduce the burden of NCD. Moreover, their association with health outcomes is 
not yet fully understood and the potential for prevention is still unexhausted. 
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Thesis Summary 
 
 
 
The four papers presented in the following contribute to an enhanced understanding of the 
associations between lifestyle risk factors as well as personality and health outcomes. By 
building a lifestyle score based on the cancer prevention recommendations of the 
WCRF/AICR 2007, the importance of lifestyle patterns was investigated with respect to 
mortality. Furthermore, the lifestyle pattern of heavy smokers and obese, two populations 
already being at high risk for adverse health outcomes, was examined. The methodological 
issues arose how to deal with continuous outcome variables like BMI in the analysis. The 
novel approach of continuous logistic outcome regression was proposed to improve statistical 
analysis by using post hoc instead of ad hoc categorization of BMI. This has the two main 
advantages of preventing information loss and improving between study comparability. The 
association between BMI and smoking was used as a case study. Personality is another 
potential risk factor for NCD and we examined its association with mortality, focusing on 
type A personality. Additionally, possible interactions with lifestyle and sociodemographic 
factors were taken into account. In the following, the papers are summarized briefly and the 
contributions of the authors are declared.  
Paper I 
Adherence to the cancer prevention recommendations of the WCRF/AICR and 
mortality: a census-linked cohort 
Tina Lohse, David Faeh, Matthias Bopp, Sabine Rohrmann for the Swiss National Cohort 
Study Group 
The importance of single lifestyle factors like smoking and physical activity has been studied 
extensively and their preventive potential has been demonstrated. But in real life non-
communicable diseases like cancer are developing under the presence of one or more risk 
factors. For lifestyle factors this corresponds to a lifestyle pattern, which is determining the 
risk of disease and mortality. In 2007, the WCRF and the AICR released common 
recommendations on cancer prevention. We built a lifestyle score including information on 
adherence to these recommendations with regard to BMI, physical activity, sedentary 
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behavior, energy density of food, as well as the consumption of fruits and vegetables, grains, 
processed meat, alcohol, and salt. We used data of the MONICA and NRP1A cohorts. By 
linking them with the SNC (census and death registry data) a mortality follow-up for up to 32 
years was established. The lifestyle score was shown to be inversely associated with all-cause 
and total cancer mortality as well as mortality from lung, upper aerodigestive tract, stomach, 
and prostate cancer. Our results strengthened the relevance of adhering to these cancer 
prevention recommendations, which are addressing the lifestyle pattern rather than only single 
risk factors in order to reduce the burden of cancer. 
TL and SR led the conceptualization and research methodology; TL wrote the first draft of the 
manuscript and conducted the statistical analysis. DF contributed his expertise during the 
process of manuscript preparation. All authors critically commented on the final version of 
the manuscript. 
Paper II 
Heavy Smoking Is More Strongly Associated with General Unhealthy Lifestyle than 
Obesity and Underweight 
Tina Lohse, Sabine Rohrmann, Matthias Bopp, David Faeh 
Heavy smokers and obese individuals are at high risk for non-communicable diseases. The 
presence of further unhealthy behaviors like physical inactivity and high alcohol intake 
further potentiates the risk. We looked at the lifestyle pattern of heavy smokers and obese 
individuals in order to investigate whether they were more likely to have an unhealthy 
lifestyle in general, compared to normal-weight never smokers. For this purpose, we used data 
of the Swiss Health Survey (1992-2012). Both heavy smokers and obese individuals were 
more likely to be physically inactive. Heavy smokers were additionally more likely to have 
high alcohol as well as low fruit and vegetable consumption. In heavy smokers the association 
was shown to be stronger, irrespectively of BMI category. Furthermore, we examined trends 
over time in prevalence and observed that the smoking prevalence decreased in normal-
weight, but not in obese individuals. Preventive measures targeting heavy smokers or obese 
individuals should take into account the co-occurrence of lifestyle risk factors, especially in 
smokers. 
TL, SR and DF led the conceptualization and research methodology; TL wrote the first draft 
of the manuscript and conducted the statistical analysis. MB contributed his expertise during 
the process of manuscript preparation. All authors critically commented on the final version 
of the manuscript. 
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Paper III 
Continuous Outcome Logistic Regression for Analyzing Body Mass Index Distributions 
Tina Lohse, Sabine Rohrmann, David Faeh, Torsten Hothorn 
Categorizing continuous outcomes before statistical analysis (i.e. ad hoc categorization) leads 
to information loss. Moreover, the usage of different categorization schemes in 
epidemiological practice makes it difficult to ensure comparability across studies, especially 
in meta-analyses covering the existing evidence irrespective of categorization schemes. The 
novel approach of continuous outcome logistic regression was developed to improve 
statistical analyses of continuous outcomes, which previously had to be categorized for 
reasons of interpretability and communication of results. By performing the categorization 
after statistical analysis (i.e. post hoc categorization), this approach prevents information loss 
by allowing the estimation and analysis of the underlying continuous distribution. 
Furthermore, it has the advantage of improving between study comparability because it is 
independent of the available outcome data. The outcome data can be continuous or categorical 
or even a mix of both. In this paper, we empirically evaluate the approach by investigating 
Body Mass Index (BMI) distributions depending on smoking and gender based on the Swiss 
Health Survey 2012. It was obvious that more restrictive models, for example a conditional 
normal distribution with or without gender- and smoking specific variance, would describe 
the BMI distributions less accurately. The obtained model results were shown to be 
insensitive regarding BMI measurement scales or categorization schemes and to match 
previously reported knowledge about the impact of smoking and sex on BMI. Continuous 
outcome logistic regression was shown to be a sophisticated procedure to analyze continuous 
outcomes without the need of categorizing outcomes ad hoc for reasons of interpretability and 
communication of results. 
TL and TH led the conceptualization and research methodology; TL and TH wrote the first 
draft of the manuscript; TH conducted the statistical analysis. DF and SR contributed their 
expertise during the process of manuscript preparation. All authors critically commented on 
the final version of the manuscript. 
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Paper IV 
Type A personality and mortality: Competitiveness but not speed is associated with 
increased risk 
Tina Lohse, Sabine Rohrmann, Aline Richard, Matthias Bopp, David Faeh for the Swiss 
National Cohort Study Group 
The concept of type A behavior pattern (TABP) was developed in the context of 
cardiovascular disease and describes a personality, which is characterized by ambitiousness, 
competitiveness, easily aroused hostility, impatience and an exaggerated sense of time 
urgency. While previous studies showed no association with cancer, contradicting results 
were observed for cardiovascular outcomes. Different definitions and measurement 
instruments of TABP might be reasons for these contradicting results, as well as not taking 
into account the individual components of the measurement instrument applied. We used the 
data of the MONICA and the NRP1A cohorts linked with the SNC (37 years of follow-up) for 
the investigation of the association between mortality and the Bortner Scale, an instrument to 
measure TABP. For this, the subscale analysis approach proposed by Edwards et al. was 
applied. This approach implies that the Bortner Scale is additionally analyzed by its subscales 
competitiveness and speed. The total Bortner Scale was shown not to be associated with 
mortality. A positive association was observed in women on the subscale competitiveness for 
all-cause, CVD, and ischemic heart disease mortality. In men, an inverse association was 
shown for CVD mortality on the subscale speed. The observed associations were independent 
of lifestyle factors. The results of the full – lifestyle factor adjusted – model differed only 
marginally from those of the crude model. Testing for interactions between the Bortner Scale 
and lifestyle factors did also not show significant results. Future studies using the Bortner 
Scale should also perform a subscale analysis and allow thereby for strengthening the 
evidence that the subscales are associated with CVD mortality in an opposed manner. In 
individuals with high health awareness, sex specific preventive measures targeting 
competitiveness and speed might offer the potential for a reduction in mortality. 
TL and DF led the conceptualization and research methodology; TL wrote the first draft of the 
manuscript and conducted the statistical analysis. DF, AR, and SR contributed their expertise 
during the process of manuscript preparation. All authors critically commented on the final 
version of the manuscript. 
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Paper I 
 
Adherence to the cancer prevention recommendations of the WCRF/AICR and 
mortality: a census-linked cohort 
Tina Lohse, David Faeh, Matthias Bopp, Sabine Rohrmann for the Swiss National Cohort 
Study Group. 
Published in the American Journal of Clinical Nutrition. 2016;104(3):678–85. 
  
 
Adherence to the cancer prevention recommendations of the World
Cancer Research Fund/American Institute for Cancer Research and
mortality: a census-linked cohort1
Tina Lohse,2* David Faeh,2,3 Matthias Bopp,2 and Sabine Rohrmann2 for the Swiss National Cohort Study Group
2Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland; and 3Health
Division-Nutrition and Dietetics, Bern University of Applied Sciences, Bern, Switzerland
ABSTRACT
Background: Modifiable lifestyle factors linked to cancer offer
great potential for prevention. Previous studies suggest an associa-
tion between adherence to recommendations on healthy lifestyle
and cancer mortality.
Objectives: The aim of this study was to examine whether adher-
ence to the cancer prevention recommendations of the World Can-
cer Research Fund (WCRF) and the American Institute for Cancer
Research (AICR) is associated with reduced all-cause, total cancer,
and specific cancer type mortality.
Design: We built a lifestyle score that included 3 categories, based
on the recommendations of the WCRF/AICR. Applying Cox re-
gression models, we investigated the association with all-cause,
total cancer, and specific cancer type mortality; in addition, we
included cardiovascular disease (CVD) mortality. We used census-
and death registry–linked survey data allowing a mortality follow-
up for #32 y. Our analysis included 16,722 participants.
Information on lifestyle score components and confounders was
collected at baseline.
Results: Over a mean follow-up of 21.7 y, 3730 deaths were
observed (1332 cancer deaths). Comparing best with poorest cat-
egory of the lifestyle score showed an inverse association with all-
cause (HR: 0.82; 95% CI: 0.75, 0.89) and total cancer (men only,
HR: 0.69; 95% CI: 0.57, 0.84) mortality. We estimated that
w13% of premature cancer deaths in men would have been pre-
ventable if lifestyle score levels had been high. Inverse asso-
ciations were observed for lung, upper aerodigestive tract,
stomach, and prostate cancer mortality [men and women com-
bined, HR: 0.72; 95% CI: 0.51, 0.99; HR: 0.49; 95% CI: 0.26,
0.92; HR: 0.34; 95% CI: 0.14, 0.83; HR: 0.48; 95% CI: 0.28, 0.82
(men only), respectively]. CVD mortality was not associated with
the lifestyle score (men and women combined, HR: 0.96; 95% CI:
0.82, 1.13).
Conclusions: Our results support the importance of adhering to rec-
ommendations for a healthy lifestyle with regard to all-cause and
cancer mortality. To reduce the burden of cancer in the population,
preventive measures should stress the potential of low-risk health
behavior patterns rather than of specific risk factors only. Am J
Clin Nutr 2016;104:678–85.
Keywords: WCRF/AICR recommendations, lifestyle, prevention,
mortality, cancer
INTRODUCTION
Modifiable lifestyle factors play a major role in the development
of noncommunicable diseases (1). For cancer prevention they offer
a great potential to reduce the burden of disease and premature
death on a population level (2–4). Smoking induces the greatest
increase in mortality risk (5), but physical inactivity, unhealthy
diet, high alcohol intake, and high BMI were also shown to be
associated with increased risk of cancer and noncommunicable
diseases in general (5–7). However, the concept of investigating
risk factors individually does not capture their distribution in the
population. Cancer has multiple lifestyle risk factors, and they are
likely to occur coincidently (8–10). Furthermore, they were shown
to act synergistically in the development of cancer (1, 7, 11, 12).
Therefore, it is of interest to assess the influence of lifestyle in its
entirety with health outcomes (13) to better understand the life-
style health outcome association.
The World Cancer Research Fund (WCRF)4 and the American
Institute for Cancer Research (AICR) launched recommenda-
tions to avoid preventable cancer cases from unhealthy behav-
iors (14). Previous studies showed an association between
adherence to these recommendations and total cancer, as well as
specific cancer type, mortality (15–17).
Our aim was to investigate this association in 2 general
population samples from Switzerland and to strengthen the
existing evidence that lifestyle in its entirety, i.e., a lifestyle score,
has an impact on the risk of preterm death. In our primary
analysis, we aimed to examine whether adherence to the cancer
1 Supported by the Swiss Cancer Research foundation (grant no. KFS-
3048-08-2012). The Swiss Federal Statistical Office provided mortality
and census data and support.
*To whom correspondence should be addressed. E-mail: tina.lohse@uzh.ch.
Received March 18, 2016. Accepted for publication June 23, 2016.
First published online August 3, 2016; doi: 10.3945/ajcn.116.135020.
4Abbreviations used: ACS, American Cancer Society; AICR, American In-
stitute for Cancer Research; CVD, cardiovascular disease; ICD, International
Classification of Diseases; ISCED, International Standard Classification of Ed-
ucation; MONICA, MONItoring of trends and determinants in CArdiovascular
disease; NRP1A, National Research Program 1A, a community-based pre-
vention of cardiovascular disease; PAF, population-attributable fraction;
RAP, rate advancement period; SNC, Swiss National Cohort; UADT, upper
aerodigestive tract; WCRF, World Cancer Research Fund.
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prevention recommendations of the WCRF/AICR was associated
with a reduced all-cause, total cancer, and specific cancer type
mortality. In addition, we investigated its association with car-
diovascular disease (CVD) mortality.
METHODS
Study design, setting, and participants
We used data from 2 population-based studies, the MONICA
(MONItoring of trends and determinants in CArdiovascular disease)
and the NRP1A (National Research Program 1A, a community-
based primary prevention of CVD). The studies were linkedwith the
SNC (SwissNational Cohort) to establish amortality follow-up. The
study participants were aged between 25 and 74 y at baseline.
As part of an international multicenter study initiated by
the WHO, 3 waves of the MONICA study were conducted in
Switzerland between 1983 and 1992 (18). The NRP1A study was
conducted from 1977 to 1979 (19). Both studies included a health
examination at baseline and a self-administered questionnaire. The
vital status of participants and cause of death were followed up
through the SNC (20, 21). The SNC is a national longitudinal
research platform linking census records with federal death and
migration records covering all residents of Switzerland. More
details about the linkage process were given elsewhere (20). Finally,
97.0% of participants in the MONICA study and 93.8% of those in
the NRP1A study were successfully linked with the SNC (21, 22).
Approval for the SNC and the linkage with MONICA and NRP1A
was obtained from the Ethics Committee of the Canton of Zurich
(KEK-StV no. 13/06 and amendment of 12 June 2008).
Variables
We built a lifestyle score according to the recommendations of the
WCRF/AICR, capturing available information from the MONICA
and NRP1A cohorts (Table 1). Information for 7 of the 8 recom-
mendations was available; only intake of dietary supplements was
not assessed. The lifestyle score ranged from 0 to 9 points: physical
activity, sedentary behavior, energy density, fruits/vegetables, grains,
processed meat, alcohol, salt, and BMI category were all rated with
0 (nonadherence), 0.5 (partial adherence to the recommendation; not
available for alcohol and grains) or 1 point (full adherence). Smoking
status, education, nationality, marital status, language region, and
study were considered as potential confounders.
Outcome
Causes of death were coded according to the International
Classification of Diseases [ICD (8th revision until 1994, 10th re-
vision since 1995)]. We investigated mortality from all causes, total
cancer (ICD-8: 140–209, 225, and 230–239; ICD-10: C00–C97,
D32–D33, and D37–D48), specific cancer type [lung (ICD-8: 162;
ICD-10: C33–C34), colorectal (ICD-8: 153–154; ICD-10: C18–
C21), upper aerodigestive tract (UADT; organs and tissues of the
respiratory tract and upper part of the digestive tract, including the
upper esophagus, but not the stomach, ICD-8: 140–150 and 161;
ICD-10: C00–C15 and C32), lymphatic and hematopoietic tissue
(abbreviated as “blood cancer” in the following—ICD-8: 200–209;
ICD-10: C81–C86, C88, and C90–C96), pancreatic (ICD-8: 157;
ICD-10: C25), urinary tract (ICD-8: 188–189; ICD-10: C67–C68),
liver (ICD-8: 155; ICD-10: C22), stomach (ICD-8: 151; ICD-10:
C16), breast (ICD-8: 174; ICD-10: C50), female genital tract
(ICD-8: 180–184; ICD-10: C51–C58), and prostate (ICD-8: 185;
ICD-10: C61)], and CVD (ICD-8: 410–458; ICD-10: I20–I99).
Data sources and assessment
Data on components of the lifestyle score and potential
confounders were assessed by self-administered questionnaires
(18, 19). Only height and weight, which were used to calculate
BMI, were measured at baseline (23).
Statistical methods
We pooled data from the 3 MONICA waves and the NRP1A,
because data collection on the variables of interest was comparable
(Table 1); the categories of the lifestyle score components in par-
ticular were identical, except for sedentary behavior, energy density,
and salt use. We decided that adding a study (including wave)
variable to all models and stratifying for study (and wave) led to
similar results. The lifestyle score was analyzed as categorical and
continuous variable. Three categories were defined as follows to
allow for a sufficient number of cases in each category: 0–3.5, 4–4.5,
and 5–9 points. We used chained imputation for the independent
variables (with a bootstrapping of 20) to increase the number of
cases available for the Cox regression. Education (9.2%, n = 1530;
NRP1A accounted for 98.1% of missing) and consumption of
energy-dense foods (17.8%, n = 2983) as a score component
contributed most to missing values (Table 1 and Table 2).
Cox regression was performed for all-cause, total cancer, specific
cancer type, and CVDmortality. In addition, we determined a priori
to stratify by sex for all-cause, total cancer, and CVD mortality. All
Cox regressionmodels were stratified by age (to prevent violation of
the proportional hazards assumption) and adjusted for smoking
status, education, nationality, marital status, language region, and
study (MONICA wave 1–3; NRP1A). Smoking status was cate-
gorized into never, former, light (1–9 cigarettes/d), moderate (10–
19 cigarettes/d), and heavy (.19 cigarettes/d). Education was
included as highest degree obtained and categorized into manda-
tory [International Standard Classification of Education (ISCED)
1–2], secondary (ISCED 3–4), and tertiary (ISCED 5–8) (24).
Nationality was included as being Swiss or foreign. Marital status
was composed of 4 categories: single, married, widowed, and di-
vorced or separated. Language region reflected cultural differences
within Switzerland, and 4 categories were taken into account:
German/Romansh, French, Italian, and German/French (bilingual
region).
A trend test was used to examinewhether the potential increase
in risk for the outcome under investigation was linear. Multi-
plicative (likelihood ratio test) interaction was considered for sex
and smoking. Additive interaction (Stata: add_int) was in-
vestigated in addition for smoking. We used the original data set
to test for trend and interaction, because in Stata those methods
are not implemented for imputed data (Stata: mi).
The relative importance of the score components was analyzed
for those causes of death being statistically significant in the Cox
regression models with the use of the imputed data set and the
continuous score. For this purpose, one component was removed
from the score, followed by our checking whether the reduced
score was still significant.
Rate advancement periods (RAPs) were calculated for all-cause
mortality only because of a lack of power for cause-specific
CANCER PREVENTION RECOMMENDATIONS AND MORTALITY 679
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mortality. Based on an age dimension, the RAP estimates how
much earlier death occurred in those being exposed than in those
being unexposed (25). In addition, we estimated population-
attributable fractions (PAFs) for all-cause and total cancer mortality.
Both RAPs and PAFs were calculated with the use of the original
data set and the categorical score.
We also performed sensitivity analyses to investigate reverse
causation. For this purpose, the first 2 y of follow-up were ex-
cluded from the analysis. Another sensitivity analysis was per-
formed to evaluate whether the results of the Cox regression were
similar, when the original rather than the imputed data set
(continuous or categorical score) was used. For the Cox re-
gression models performed with the original data set, an addi-
tional category was created for confounding variables with
missing values. All analyses were performed with the use of Stata
13.1; RAPs were calculated with the use of R statistical software
version 3.2.3.
RESULTS
The study included 16,722 participants (8161 men and 8561
women) with a mean follow-up of 21.7 y (men, 20.9 y, and
TABLE 1
Operationalization of the lifestyle score by study1
Score component Recommendation Operationalization Category Distribution, %
BMI Maintain body weight within the
normal range from age 21 y
MONICA and NRP1A: 0; 0.5; 1; missing 12.9; 35.9; 51.1; 0.1
BMI (in kg/m2): 18.5–24.9 = 1, 25–29.9 = 0.5,
,18.5 or $30 = 0
Physical activity Be moderately physically active,
equivalent to brisk walking, for $30
min every day. As fitness improves,
aim for $60 min of moderate or
$30 min of vigorous physical
activity every day
MONICA and NRP1A: 0; 0.5; 1; missing 55.7; 21.7; 20.6; 2.0
$2 d/wk = 1, 1 d/wk = 0.5, ,1 d/wk = 0
Sedentary behavior Limit sedentary habits such as watching
television
MONICA: 0; 0.5; 1; missing 30.6; 58.0; 9.7; 1.7
Level of physical activity: mostly sitting = 0;
walking, cycling, other regular activities such
as gardening = 0.5; regular exercise = 1
NRP1A:
Level of physical activity: sedentary (such as
watching TV) = 0; average (such as walking,
gymnastics, and badminton) = 0.5;
exhausting (such as soccer, chopping wood,
and digging) = 1
Energy density Consume energy-dense foods sparingly MONICA: 0; 0.5; 1; missing 16.9; 34.5; 30.7; 17.8
Fat for cooking, bread, or salad (not butter or
lard) = 1 + cut away fat from meat (always or
often) = 1 + sweets yesterday (no) = 1*
NRP1A:
Fat for cooking, bread, or salad = 1 + cut away
fat from meat (always or often) = 1+
chocolate yesterday (no) = 1*
Fruits and vegetables Eat$5 portions or servings ($400 g or
14 oz) of a variety of fruits and
nonstarchy vegetables every day
MONICA and NRP1A: 0; 0.5; 1; missing 17.5; 48.1; 31.9; 2.6
Yesterday: no fruits or vegetables = 0, either
fruits or vegetables = 0.5, both fruits and
vegetables = 1
Grains Eat relatively unprocessed cereals
(grains) and/or pulses (legumes) with
every meal
MONICA and NRP1A: 0; 1; missing 54.0; 43.9; 2.1
Yesterday: no = 0, yes = 1
Processed meat For people who eat red meat, consume
,500 g (18 oz) red meat/wk; very
little if any as processed meat
MONICA and NRP1A: 0; 0.5; 1; missing 27.7; 53.8; 17.2; 1.3
Yesterday: sausage products = 0; meat = 0.5;
none = 1
Alcohol If alcoholic drinks are consumed, limit
consumption to #2 drinks/d for men
and 1 drink/d for women
MONICA and NRP1A: 0; 1; missing 55.9; 43.4; 0.7
Yesterday: yes = 0, no = 1
Salt Avoid salt-preserved, salted, or salty
foods; preserve foods without the use
of salt
MONICA: 0; 0.5; 1; missing 6.2; 43.5; 49.7; 0.5
Adding salt: always = 0, sometimes = 0.5,
never = 1
NRP1A:
Adding salt: always or often = 0, seldom or
almost never 0.5, never = 1
1Only WCRF/AICR recommendations that could be operationalized are shown. *Energy-dense food: sum 0 = 0, 1 = 0.5, 2 or 3 = 1. AICR, American
Institute for Cancer Research; MONICA, MONItoring of trends and determinants in CArdiovascular disease; NRP1A, National Research Program 1A,
a community-based primary prevention of cardiovascular disease; WCRF, World Cancer Research Fund.
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women, 22.4 y) (Table 2). The mean age at baseline was 45.8 y
in men and 46.3 y in women. Participants within the highest
lifestyle score category, i.e., most adherent to a cancer-preventive
lifestyle, were younger, more often never smoked and were
Swiss nationals, less often were divorced or separated, and had
a higher level of education. In addition, the proportion of
participants with a high lifestyle score was greater in the
NRP1A. Adherence to the recommendations was rather low for
physical activity, sedentary behavior, and processed meat con-
sumption (Table 1).
TABLE 2
Characteristics of the study participants by lifestyle score categories and sex1
Lifestyle score category
All 1 2 3 Imputed
Men 8161 (100.0) 2072 (25.4) 1842 (22.6) 2309 (28.3) 1938 (23.8)
Age, y 45.8 6 12.0 46.3 6 11.2 45.1 6 11.7 44.1 6 12.4 48.0 6 12.1
Survival, y 20.9 6 7.6 20.3 6 7.4 21.4 6 7.5 22.4 6 7.7 19.4 6 7.6
Smoking
Never 2214 (27.1) 452 (21.8) 485 (26.3) 763 (33.0) 514 (26.5)
Former 2177 (26.7) 572 (27.6) 487 (26.4) 620 (26.9) 498 (25.7)
Light 884 (10.8) 191 (9.2) 206 (11.2) 285 (12.3) 202 (10.4)
Moderate 783 (9.6) 216 (10.4) 177 (9.6) 213 (9.2) 177 (9.1)
Heavy 1852 (22.7) 582 (28.1) 430 (23.3) 353 (15.3) 487 (25.1)
Imputed 251 (3.1) 59 (2.9) 57 (3.1) 75 (3.3) 60 (3.1)
Study
MONICA I 1699 (20.8) 548 (26.5) 364 (19.8) 331 (14.3) 456 (23.5)
MONICA II 1750 (21.4) 592 (28.6) 421 (22.9) 461 (20.0) 276 (14.2)
MONICA III 1520 (18.6) 294 (14.2) 304 (16.5) 350 (15.2) 572 (29.5)
NRP1A 3192 (39.1) 638 (30.8) 753 (40.9) 1167 (50.5) 634 (32.7)
Education
Mandatory 1982 (24.3) 607 (29.3) 424 (23.0) 356 (15.4) 595 (30.7)
Upper secondary 4027 (49.3) 1012 (48.8) 926 (50.3) 1192 (51.6) 897 (46.3)
Tertiary 1632 (20.0) 363 (17.5) 381 (20.7) 573 (24.8) 315 (16.3)
Imputed 520 (6.4) 90 (4.3) 111 (6.0) 188 (8.1) 131 (6.8)
Nationality
Swiss 6363 (78.0) 1531 (73.9) 1445 (78.5) 1934 (83.8) 1453 (75.0)
Foreign 1796 (22.0) 539 (26.0) 397 (21.6) 375 (16.2) 485 (25.0)
Imputed 2 (0.0) 2 (0.1) 0 (0) 0 (0) 0 (0)
Women 8561 (100.0) 1345 (15.7) 1881 (22.0) 3710 (43.3) 1625 (19.0)
Age, y 46.3 6 12.5 46.4 6 11.9 46.2 6 12.3 45.0 6 12.3 49.7 6 12.9
Survival, y 22.4 6 7.0 21.3 6 6.8 22.0 6 6.7 23.2 6 6.8 21.9 6 7.7
Smoking
Never 4884 (57.1) 695 (51.7) 1017 (54.1) 2140 (57.7) 1032 (63.5)
Former 1256 (14.7) 186 (13.8) 300 (16.0) 603 (16.3) 167 (10.3)
Light 545 (6.4) 94 (7.0) 108 (5.7) 247 (6.7) 96 (5.9)
Moderate 765 (8.9) 129 (10.0) 195 (10.4) 306 (8.3) 135 (8.3)
Heavy 795 (9.3) 186 (13.8) 197 (10.5) 275 (7.4) 137 (8.4)
Imputed 316 (3.7) 55 (4.1) 64 (3.4) 139 (3.8) 58 (3.6)
Study
MONICA I 1625 (19.0) 372 (27.7) 407 (21.6) 581 (15.7) 265 (16.3)
MONICA II 1654 (19.3) 341 (25.4) 462 (24.6) 758 (20.4) 93 (5.7)
MONICA III 1605 (18.8) 238 (17.7) 344 (18.3) 616 (16.6) 407 (25.1)
NRP1A 3677 (43.0) 394 (29.3) 668 (35.5) 1755 (47.3) 860 (52.9)
Education
Mandatory 3369 (39.4) 653 (48.6) 807 (42.9) 1165 (31.4) 744 (45.8)
Upper secondary 3223 (37.7) 483 (35.9) 701 (37.3) 1559 (42.0) 480 (29.5)
Tertiary 959 (11.2) 125 (9.3) 213 (11.3) 490 (13.2) 131 (8.1)
Imputed 1010 (11.8) 84 (6.3) 160 (8.5) 496 (13.4) 270 (16.6)
Nationality
Swiss 7173 (83.8) 1061 (78.9) 1507 (80.1) 3268 (88.1) 1337 (82.3)
Foreign 1356 (15.8) 277 (20.6) 367 (19.5) 426 (11.5) 286 (17.6)
Imputed 32 (0.4) 7 (0.5) 7 (0.4) 16 (0.4) 2 (0.1)
1Values are means6 SDs or n (%). Missing information on score components and covariates were imputed for the Cox
regression so that the whole sample could be included. For all other analyses, subjects with missing information could not be
included. Data for marital status and language region are not shown. MONICA, MONItoring of trends and determinants in
CArdiovascular disease; NRP1A, National Research Program 1A, a community-based primary prevention of cardiovascular
disease.
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In total, 3730 deaths occurred, of which 1332 were caused
by cancer and 1178 by CVD (Table 3). Lung (n = 259), blood
(n = 145), and colorectal (n = 113) were the most common cancer-
specific sites. Stomach (n = 39), urinary tract (n = 50), and liver
(n = 51) were the rarest ones.
Both the categorical and the continuous lifestyle scores were
inversely associated with all-cause and total cancer mortality, but
not with CVD mortality (Table 3). Sex-stratified analyses of the
categorical score showed that the association with all-cause
mortality was stronger in men than in women (men, HR: 0.80;
95% CI: 0.71, 0.90; women, HR: 0.85; 95% CI: 0.73, 0.98, most
compared with least adherent). In men, the risk of dying was even
statistically significant when comparing low and moderate levels
of the lifestyle score (HR: 0.87; 95% CI: 0.77, 0.98). The risk of
dying from cancer (all sites) was inversely associated with the
lifestyle score in men (HR: 0.69; 95% CI: 0.57, 0.84). Lung,
UADT, stomach, and prostate cancer mortality also were in-
versely associated when comparing lowest and highest levels of
the lifestyle score (HR: 0.72; 95% CI: 0.51, 0.99; HR: 0.49; 95%
CI: 0.26, 0.92; HR: 0.34; 95% CI: 0.14, 0.83; HR: 0.48; 95% CI:
0.28, 0.82, respectively). Results were similar for the continuous
score. We did not observe statistically significant interaction
(neither additive nor multiplicative) of the lifestyle score with
smoking, but we did observe significant interaction with sex for
cancer mortality (multiplicative; P-interaction = 0.047 continu-
ous and 0.616 categorical) and CVD mortality (multiplicative;
P-interaction = 0.688 continuous and 0.036 categorical).
No statistically significant associations were observed when
physical activity and sedentary behavior (all-cause mortality in
women, and lung, and UADT cancer mortality) or BMI (all-cause
mortality in women, and stomach, and prostate cancer mortality)
were excluded from the score. Removing nutritional score
components led to nonsignificant results with regard to lung and
UADT cancer mortality (intake of fruits and vegetables, alcohol,
and grains; salt in UADT only) (data not shown).
For the calculation of RAPs and PAFs, we used the original
data set, which included 11,586 participants (5657 men and 5929
women). In men, additional gain of lifetime was greatest in those
having low compared with moderate or high lifestyle score levels
(1.15 y; 95% CI: 0.49, 1.81 y); high lifestyle scores did not add
much (low and moderate compared with high, 1.17 y; 95% CI:
0.48, 1.88 y). In women, RAPs were not statistically significant
(low compared with moderate and high, 0.84 y; 95% CI: 20.32,
1.99 y), and low and moderate compared with high, 0.65 y; 95%
CI: 20.17, 1.46 y). We estimated that w6% (6.06%; 95% CI:
1.66%, 10.27%; in men, 8.03%; 95% CI: 1.28%, 14.32%) of
premature deaths would have been preventable if all lifestyle
score levels had been high. For total cancer mortality, the esti-
mated PAF was even higher. Approximately 8% (7.93%; 95%
CI: 0.34%, 14.96%; in men, 13.08%; 95% CI: 1.13%, 23.58%)
of premature cancer deaths could have been prevented. In
women, PAFs were not statistically significant (all-cause mor-
tality, 4.17%; 95% CI: 21.21%, 9.27%; total cancer mortality,
3.81%; 95% CI:25.79%, 12.54%). PAFs differed by cohort; the
estimates were larger in the MONICA cohort (data not shown).
The sensitivity analysis on reverse causation, i.e., exclusion of
the first 2 y of follow-up, showed changing results for CVD
mortality from no association to a significant association (con-
tinuous score, men and women combined, 0.94; 95% CI: 0.89,
0.99), but no change in the results for all-cause or total cancer
mortality. Results of the Cox regression were consistent for all-
cause, total cancer, lung cancer, prostate cancer, and CVD
mortality: use of the imputed or the original data set did not
change the results appreciably. UADT and stomach cancer
mortality results were comparable in the imputed data set for the
categorical and the continuous lifestyle scores. But for the
original data set, no significant associations were observed, which
most likely was because of the small number of UADT and
stomach cancer deaths.
DISCUSSION
Adherence to the recommendations of the WCRF/AICR was
associated with reduced all-cause and total cancer mortality, as
well as lung, UADT, stomach, and prostate cancer mortality.
However, the association with cancer mortality was statistically
significant in men only.
Our results strengthen the existing evidence that adherence to
a healthy lifestyle is associated with all-cause and total cancer
mortality (15–17). Others showed the relevance of a general
healthy lifestyle to prevent cancer and reduce all-cause mortality
by building a lifestyle score based on the recommendations of
the AICR only (26) or the American Cancer Society (ACS) (27–
29). However, in our study, the association was considerably
weaker for women than for men. We assume that this was due to
an overall healthier behavior in women.
In line with our results, Romaguera et al. (16) observed sig-
nificant associations of the WCRF/AICR score with stomach,
lung, and UADT cancer, but not with prostate cancer. Although
our estimates were larger, the greatest association was also shown
for stomach cancer, followed by UADT and lung cancers.
Romaguera et al. (16) showed a relation of the lifestyle score with
colon, breast, endometrial, kidney, liver, and esophagus cancers,
which we did not see in our study. Kabat et al. (29) used the
recommendations of the ACS to build a score of adherence, and
showed significant associations for 16 cancer-specific sites. The
strongest associations were observed for gallbladder, endome-
trial, liver, and colon cancer. Several studies investigated whether
specific cancer types were associated with the WCRF/AICR
recommendations on lifestyle. Most studies focused on breast
cancer (30–34), but also colorectal (35) and pancreatic (36)
cancer risk were investigated. Results of these studies showed
consistently that cancer incidence was reduced if adherence to
the WCRF/AICR recommendations was high (30, 32–36); only
Fanidi et al. (31) did not observe an association between breast
cancer risk and adherence to the WCRF/AICR recommenda-
tions. In our analysis, we did not observe an association of the
WCRF/AICR score with the risk of dying from colorectal can-
cer. This is in contrast to several previous studies and might be
due to a small number of cases.
Similar to us, Cerhan et al. (26) did not observe an association of
adherence to the AICR recommendations with CVD mortality in
a female population. But in our sensitivity analysis, the exclusion of
the first 2 y of follow-up yielded a significant association of the
lifestyle score with CVD mortality. This may indicate reverse
causation, i.e., participants might have changed their lifestyle after
having been diagnosed with, e.g., hypertension or myocardial in-
farction. McCullough et al. (27) and Vergnaud et al. (17) observed
an association with CVDmortality when applying the ACS and the
WCRF/AICR recommendations, respectively.
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TABLE 3
HRs (95% CIs) for the association between the lifestyle score and all-cause, total cancer, specific cancer type, and CVD
mortality1
Mortality
Lifestyle score
Categorical Continuous
12 2 3 Missing P-trend3 P-trend3
All-cause
Overall 1 0.87 (0.79, 0.95) 0.82 (0.75, 0.89) 0.004 0.93 (0.90, 0.95) 0.001
Cases, n 766 759 1190 1015
Men 1 0.87 (0.77, 0.98) 0.80 (0.71, 0.90) 0.075 0.91 (0.88, 0.95) 0.012
Cases, n 534 442 541 569
Women 1 0.90 (0.76, 1.05) 0.85 (0.73, 0.98) 0.681 0.94 (0.91, 0.99) 0.475
Cases, n 232 317 649 446
Interaction for sex 0.374 0.065
Cancer
Overall 1 0.83 (0.72, 0.97) 0.74 (0.64, 0.86) 0.001 0.90 (0.86, 0.94) 0.001
Cases, n 300 284 408 340
Men 1 0.80 (0.66, 0.97) 0.69 (0.57, 0.84) 0.001 0.87 (0.81, 0.93) 0.001
Cases, n 211 158 172 212
Women 1 0.91 (0.70, 1.17) 0.80 (0.64, 1.01) 0.645 0.94 (0.88, 1.01) 0.672
Cases, n 89 126 236 128
Interaction for sex 0.616 0.047
Specific cancer types
Lung 1 0.93 (0.68, 1.28) 0.72 (0.51, 0.99) 0.001 0.90 (0.81, 1.00) 0.001
Cases, n 71 61 55 72
UADT 1 0 0.82 (0.47, 1.45) 0.49 (0.26, 0.92) 0.002 0.82 (0.67, 1.00) 0.003
Cases, n 23 19 15 18
Stomach 1 0.60 (0.25, 1.39) 0.34 (0.14, 0.83) 0.021 0.71 (0.54, 0.95) 0.028
Cases, n 11 4 6 18
Colorectal 1 1.15 (0.68, 1.96) 0.84 (0.50, 1.42) 0.912 0.86 (0.73, 1.02) 0.653
Cases, n 18 26 35 34
Liver 1 0.56 (0.25, 1.26) 1.07 (0.54, 2.11) 0.909 0.98 (0.77, 1.24) 0.633
Cases, n 12 8 20 11
Pancreatic 1 0.83 (0.43, 1.60) 0.65 (0.35, 1.20) 0.754 0.88 (0.72, 1.07) 0.804
Cases, n 15 16 24 17
Urinary tract 1 0.38 (0.15, 0.97) 0.63 (0.31, 1.28) 0.835 0.99 (0.78, 1.26) 0.747
Cases, n 13 7 19 11
Blood 1 1.24 (0.76, 2.02) 1.04 (0.65, 1.67) 0.124 0.98 (0.85, 1.13) 0.070
Cases, n 21 36 58 30
Prostate 1 0.67 (0.39, 1.18) 0.48 (0.28, 0.82) 0.053 0.79 (0.66, 0.95) 0.092
Cases, n 32 18 21 27
Breast 1 0.67 (0.36, 1.24) 0.76 (0.45, 1.30) 0.439 0.91 (0.77, 1.08) 0.265
Cases, n 18 18 37 25
FGT 1 0.82 (0.40, 1.65) 0.66 (0.35, 1.25) 0.799 0.90 (0.73,1.09) 0.646
Cases, n 11 16 33 14
CVD
Overall 1 0.92 (0.77, 1.09) 0.96 (0.82, 1.13) 0.203 0.97 (0.92,1.02) 0.539
Cases, n 208 226 394 350
Men 1 0.91 (0.72, 1.13) 0.97 (0.79, 1.18) 0.087 0.99 (0.92,1.06) 0.177
Cases, n 148 135 194 188
Women 1 0.94 (0.69, 1.28) 0.97 (0.74, 1.28) 0.312 0.95 (0.88,1.03) 0.820
Cases, n 60 91 200 162
Interaction for sex 0.036 0.688
1Cox regression with the use of the imputed data set; models were adjusted for education, marital status, study,
language region, nationality, and smoking status. CVD, cardiovascular disease; FGT, female genital tract; UADT, upper
aerodigestive tract.
2Reference category.
3
P-trend test for linearity and likelihood ratio test for multiplicative interaction, with the use of the original data set.
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Similar to others, we observed that removing one component
of the lifestyle score did not appreciably change the association
observed for total cancer mortality (men and women combined)
(17), but the relative importance of individual score components
differed with respect to their relevance for specific cancer types
(16). For example, for lung and UADT cancer mortality, physical
activity, sedentary behavior, and nutrition seemed to be of greater
importance than the other lifestyle score components.
We observed statistically significant RAPs for all-cause
mortality in men, but not in women. The estimate ofw1.2 y was
similar to what was found by others; however, their estimation
was for both men and women combined (17). For fruit and
vegetable consumption, the estimated RAP was comparable
with the 1.12 y observed in the European Prospective In-
vestigation into Cancer and Nutrition (37). In relation to
smoking, these estimates for all-cause mortality were smaller.
The Chances Consortium observed RAPs of 6.4 y for current
smokers and 2.4 y for former smokers compared with never
smokers (38). In the third NHANES, the RAP for the combi-
nation of 4 lifestyle factors (all compared with none: never
smoking, healthy diet, adequate physical activity, and moderate
alcohol consumption) was estimated to be 11.1 y for all-cause
mortality (39).
Approximately 25% of cancer deaths in Western countries
were estimated to be preventable by adherence to common
recommendations on diet, nutrition, physical activity, and body
fatness (40). Our estimate of 8% was much lower than that. But
others also observed a lower estimate of w12%, and, as they
already discussed (16), this might be due to the fact that our
study population was healthier than the general population (41)
and that the prevalence of adherence to the recommendations
was considerably greater in the NRP1A cohort.
Our study had strengths and limitations. The whole range of
the lifestyle score was represented in our study, and participants
were followed for up to 32 y, with low loss to follow-up. The
exposure was assessed only once at baseline by self-report, which
might have biased the results toward the null. A person’s lifestyle
is rather stable over the life course, but individuals tend to
overreport or overestimate presumed healthy behaviors. This
might be especially true for the NRP1A, designed as a primary
prevention intervention in which participants were educated on
behaviors defined as healthy and therefore might have even
more strongly overreported or overestimated healthy behaviors.
Our analysis included all components of the WCRF/AICR rec-
ommendations, except for the intake of dietary supplements.
The assessment of the lifestyle score components was similar for
the 2 cohorts pooled, and the bias introduced by pooling is ex-
pected to be minor. The available data on dietary intake was
limited, given that only the 24-h recall has been assessed. In
a previous analysis, we showed that including the variables on
“was yesterday a weekday” and “was yesterday a normal or an
unusual day regarding your diet” did not affect the association
(42). Equal weights were given to the risk factors included in the
lifestyle score and an overall estimate was calculated, not taking
into account differences between specific cancer types. Fur-
thermore, it has to be taken into account that we investigated the
association of adherence to the WCRF/AICR recommendations
with mortality only and not with incident cases. By performing
data imputation, we were able to present more precise estimates
of the association under investigation without changing the
association, as shown by the sensitivity analysis. Nevertheless,
the number of cases was relatively low for some cancer-specific–
type mortalities, especially stomach, urinary tract, and liver cancers;
therefore, the results have to be interpreted with caution. Con-
cerning generalizability, we assume that the results of our analysis
tend to underestimate the real association between mortality and
healthy lifestyle.
In conclusion, our results support the importance of a general
healthy lifestyle with regard to all-cause and cancer mortality. To
reduce the burden of cancer in the population, preventive mea-
sures should stress the potential of low-risk health behavior and
communicate the diverse opportunities for improvement, rather
than focusing on specific risk factors only. To deepen our un-
derstanding of the association between cancer and lifestyle,
future research should consider a life course approach.
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Abstract
Background
Smoking and obesity are major causes of non-communicable diseases. We investigated
the associations of heavy smoking, obesity, and underweight with general lifestyle to infer
which of these risk groups has the most unfavourable lifestyle.
Methods
We used data from the population-based cross-sectional Swiss Health Survey (5 rounds
1992–2012), comprising 85,575 individuals aged!18 years. Height, weight, smoking, diet,
alcohol intake and physical activity were self-reported. Multinomial logistic regression was
performed to analyse differences in lifestyle between the combinations of body mass index
(BMI) category and smoking status.
Results
Compared to normal-weight never smokers (reference), individuals who were normal-
weight, obese, or underweight and smoked heavily at the same time had a poorer general
lifestyle. The lifestyle of obese and underweight never smokers differed less from reference.
Regardless of BMI category, in heavy smoking men and women the fruit and vegetable con-
sumption was lower (e.g. obese heavy smoking men: relative risk ratio (RRR) 1.69 [95%
confidence interval 1.30;2.21]) and high alcohol intake was more common (e.g. normal-
weight heavy smoking women 5.51 [3.71;8.20]). In both sexes, physical inactivity was
observed more often in heavy smokers and obese or underweight (e.g. underweight never
smoking 1.29 [1.08;1.54] and heavy smoking women 2.02 [1.33;3.08]). A decrease of smok-
ing prevalence was observed over time in normal-weight, but not in obese individuals.
Conclusions
Unhealthy general lifestyle was associated with both heavy smoking and BMI extremes, but
we observed a stronger association for heavy smoking. Future smoking prevention
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measures should pay attention to improvement of general lifestyle and co-occurrence with
obesity and underweight.
Introduction
Smoking and obesity are the most important modifiable risk factors of non-communicable dis-
eases (NCD) [1–3]. Evidence is less clear for underweight [4,5]. However, similarly to obese
individuals and smokers, it was shown that underweight individuals have an increased risk of
premature death [6,7]. Investigations of the health impact of extreme body mass index (BMI)
combined with smoking found that obese and underweight current smokers had the highest
overall, cancer and cardiovascular disease mortality risk [8]. Non-smoking and maintaining
healthy BMI, but also related risk factors such as healthy diet, low to moderate alcohol intake
and physical activity offer substantial potential for the reduction of premature death and NCD
burden in the population [9,10].
Unfavourable lifestyle factors are likely to occur coincidentally. Studies on how lifestyle fac-
tors are related and cluster revealed that smoking and educational level are driving factors,
unfortunately they did not take BMI into account [11–13]. In affluent countries like Switzer-
land, obesity gained relevance as its prevalence was increased over the past decades, whereas
the prevalence of smoking decreased in the general population [14,15]. However, it remains
unknown whether this decrease occurred also in those most at risk (i.e. obese individuals) or
mainly in healthier and health conscious people. Therefore we aimed to investigate the general
lifestyle of obese individuals, heavy smokers, and obese heavy smokers to get a better under-
standing of the distribution of lifestyle risk factors. These populations are already at high risk
of NCD and the coincidence with further unhealthy lifestyles would worsen their risk profile.
We also included underweight in our analysis to contribute to the discussion on whether the
increased mortality risk of underweight individuals is explained by associated lifestyle factors
[6,16].
It was our first objective to compare the role of obesity, underweight and heavy smoking
regarding the tendency of clustering with other NCD relevant lifestyle factors and with socio-
demographic factors. Secondly, we aimed at investigating the temporal changes in the preva-
lence of the combination of obesity and underweight respectively with heavy smoking.
Methods
Population and data collection
The Swiss Health Survey (SHS) is a population-based cross-sectional survey conducted every 5
years since 1992 by the Swiss Federal Statistical Office [17]. Study samples were obtained by
stratified random sampling out of a database containing all private household landline tele-
phone numbers. This database was built with linkage of data from resident registries and tele-
phone companies. Since 2012, an additional recruitment option was implemented. For those
subjects who were randomly selected through resident registries and had no landline telephone
number available, a letter was sent out to obtain contact information (landline or mobile tele-
phone number) by prepaid answer postcard. Data was collected with telephone interview and
self-administered questionnaire, additionally. The participation rate ranged from 71% in 1992
to 54% in 2012. For this study, we restricted the sample to individuals aged!18 years.
The data collection and data storage for the SHS does not require formal approval by an eth-
ical committee. This data collection is specifically permitted under Swiss law (Verordnung
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über die Durchführung von statistischen Erhebungen des Bundes vom 30. Juni 1993 (SR
431.012.1) and Verordnung über die eidgenössische Volkszählung vom 19. Dezember 2008
(SR 431.112.1)). Individuals invited to participate received a brief description of the study and
could decline to participate or withdraw at any time. Participants’ responses were treated confi-
dentially and aggregated anonymous responses were utilized for analyses presented herein.
Outcome
Height, weight, and smoking status were self-reported by telephone interview (see S1 Table).
BMI was calculated as weight in kilograms divided by the square of height in metres. We cate-
gorized BMI (kg/m2) into underweight<18.5, normal-weight!18.5–<25, overweight!25–<
30, and obesity!30 [18]; smoking status into never, former, light (1–9 cigarettes per day),
moderate (10–19), and heavy smokers (>19). Never smokers stated that they did not currently
smoke and never regularly smoked during more than six months; former smokers reported not
smoking currently but having smoked for more than 6 months during their life course. One
cigarillo or pipe was counted as 2 cigarettes and 1 cigar as 4 cigarettes. The outcome variable
had 20 categories, composed of the combination of BMI category and smoking status.
Exposure and Covariates
We selected three lifestyle proxies in order to explore the general health behaviour. These were
assessed by telephone interview and self-administered questionnaire: fruit and vegetable con-
sumption, physical activity, and alcohol intake. In Switzerland, fruit and vegetable consump-
tion—as healthy diet proxy—was associated with lower mortality, also in combination with
other NCD factors [10]. For all 5 rounds of the SHS information on the number of days per
week fruits and vegetables were consumed was available. We chose to categorize as closest to
the "5-a-day" recommendation as possible [19]. Because of the inconsistency of the collected
information across surveys, we had to choose a fairly crude categorisation. Fruit and vegetable
consumption was combined in one binary variable that comprised the information on whether
both fruits and vegetables were consumed daily or not. We previously showed the importance
of leisure-time physical activity in avoiding premature death [20]; hence we included weekly
leisure-time physical activity in the analysis. The variable was defined as the number of days
per week a subject started to sweat during leisure time physical activity and was categorized as
>2 days, 1–2 days, and none. Alcohol intake was categorized into low, moderate, and high
based on its sex specific risk for adverse health consequences. For men, the cut-offs were<40
to<60g of alcohol per day, for women<20 to<40g. For 4,500 participants of the SHS 1992,
information on alcohol intake was only available from the telephone interview. Because this
information was not comparable to that obtained from the questionnaire, we added a missing
category to the alcohol variable. Education was included as highest degree obtained and was
categorized into mandatory (International Standard Classification of Education, ISCED 1–2),
secondary II (ISCED 3–4), and tertiary (ISCED 5–8) [21].
Statistical analysis
We pooled the data of the five SHS and included a survey variable in the model. All analyses
were weighted to the general population of Switzerland [17] and stratified by sex. We stratified
for sex because of existing evidence for variations between sexes which also were obvious in
our data. Differences in prevalence of smoking status and BMI categories were substantial
between men and women as well as in the distribution of the exposures (fruit and vegetables,
physical activity, and alcohol intake). Furthermore, it is known that the reasons for smoking
vary by sex and this may lead to differences in their association with further lifestyle factors
General Lifestyle of Smokers, Obese, and Underweight
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[22,23]. We performed multinomial logistic regression (STATA command: mlogit) in order to
examine whether heavy smoker, obese or underweight individuals as well as obese and under-
weight heavy smokers were prone to have additional unhealthy lifestyle factors, compared to
normal-weight never smokers. Multinomial regression was used to investigate associations
between a categorical outcome with more than 2 categories and the exposure. The outcome
was defined as a categorical variable obtained by the combination of BMI category with smok-
ing status category. All smoking-BMI-category-combinations (4x5) were included in the analy-
ses. However, for this study, we focussed on the results for heavy smoking and BMI extremes
(underweight and obesity) and their presentation. The three lifestyle variables were included in
the model, as well as educational level, nationality, language region, survey (categorisation, see
Tables 1 and 2), and age. We pooled the data of the 5 SHS rounds, which enabled us to investi-
gate changes over time. This was done through interpreting the results of the survey variable
Table 1. Demographic characteristic, BMI category, smoking status, and survey.
Men Women
Mean age 46.0* 47.9*
n %* n %*
Nationality
Swiss 28985 79.3 37450 83.4
Foreign 5256 20.7 5100 16.6
Education
Tertiary 10814 31.0 6772 15.3
Secondary II 19412 56.0 26970 63.7
Mandatory 4015 12.0 8808 21.0
Language region
German 22761 72.8 27532 71.2
French 9022 22.8 11686 24.0
Italian 2458 4.4 3332 4.8
BMI category
Underweight 302 0.9 2628 6.3
Normal-weight 17748 52.4 27320 64.7
Overweight 13196 38.3 9263 21.5
Obese 2995 8.4 3339 7.5
Smoking status
Never 14063 41.3 24431 58.4
Former 9515 26.9 8117 18.6
Light 2799 08.4 3236 7.8
Medium 3100 09.5 3524 8.1
Heavy 4764 13.9 3242 7.1
Survey
1992 6003 18.8 7574 19.0
1997 5063 19.7 6518 19.8
2002 7389 18.8 9489 19.4
2007 7015 19.7 9064 19.5
2012 8771 23.0 9905 22.3
N Total 34241 100.0 42550 100.0
* weighted according to the general population of Switzerland.
doi:10.1371/journal.pone.0148563.t001
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that was entered into the multinomial regression model. The regression model provided rela-
tive risk ratios (RRR) [24].To assess the public health relevance, the absolute number of indi-
viduals per BMI category, smoking status, and selected combinations of smoking and BMI
were estimated for Switzerland in 2012 by an extrapolation based on SHS 2012 and STATPOP
2012 (Statistics of population and households) [25]. All analyses were performed using STATA
13.1, College Station, TX, USA.
Results
Descriptive
Our analysis included 85,575 individuals. Table 1 shows the distribution of BMI and smoking
status categories and demographic characteristics of the study participants by sex (BMI and
smoking combinations see S2 Table, lifestyle exposures see S3 Table). Women were on average
older than men, whereas there were only negligible differences in nationality and distribution
over language regions. The proportion of individuals with tertiary education was twice as high
in men compared to women. The prevalence of obesity was comparable in men and women,
but the proportion of women with underweight was 6 times higher. Heavy smoking was twice
as frequent in men compared to women.
Table 2. Estimated absolute numbers (N) and proportions (%*) for smoking status, BMI, and selected smoking-BMI-combinations in Switzerland
2012.
Men Women
n %* n %*
BMI
Underweight 25 771 0.8 193 971 5.8
Normal-weight 1 523 051 47.3 2 061 801 61.4
Overweight 1 296 723 40.3 780 803 23.2
Obese 372 537 11.6 322 836 9.6
Smoking status
Never 1 466 277 45.6 1 999 815 59.5
Former 888 659 27.6 678 057 20.2
Light 263 114 8.2 271 525 8.1
Medium 295 869 9.2 262 438 7.8
Heavy 304 163 9.4 147 575 4.4
Smoking—BMI—combination
Normal-weight/ Never smoker 756 523 23.5 1 213 258 36.1
Underweight/ Never smoker 15 485 0.5 119 422 3.6
Overweight/Never smoker 544 589 16.9 460 612 13.7
Obese/ Never smoker 148 484 4.6 202 028 6.0
Normal-weight/ Heavy smoker 138 192 4.3 85 537 2.5
Underweight/ Heavy smoker 3 861 0.1 10 566 0.3
Overweight/Heavy smoker 121 667 3.8 38 493 1.1
Obese/ Heavy smoker 41 910 1.3 14 299 0.4
Total 3 218 082 100.00 3 359 410 100.00
Extrapolation based on SHS 2012 (prevalence) and STATPOP 2012 (Statistics of population and households), permanent resident population aged ! 18
years, by sex.
* weighted according to the general population of Switzerland.
doi:10.1371/journal.pone.0148563.t002
General Lifestyle of Smokers, Obese, and Underweight
PLOS ONE | DOI:10.1371/journal.pone.0148563 February 24, 2016 5 / 13
Fig 1 shows the distribution of smoking status by sex for Switzerland in 2012. For heavy and
never smoking, combinations with BMI categories are presented in detail. Table 2 shows the
corresponding proportions and estimated absolute numbers for Switzerland in 2012. In never
and heavy smokers, the proportion of underweight and overweight individuals was comparable
in both sexes. However, comparing male never with heavy smokers, the proportion of normal-
weight individuals was smaller (never: 52 vs heavy: 45%) whereas the proportion of obese indi-
viduals was larger (never: 10 vs heavy: 14%). This difference was smaller in females (61 vs 57%;
10 vs 9%). Sex differences also existed with respect to the prevalence of the combination obesity
plus heavy smoking. It was found to be 1.3% in men and 0.5% in women. Men were also more
likely to be normal-weight heavy smokers. On the other hand, women were more often obese
never smokers, underweight never and heavy smokers, respectively.
Regression analysis
Compared to reference, i.e. normal-weight never smokers, individuals who were normal-
weight, obese, or underweight and smoked heavily at the same time had a poorer lifestyle
(Table 3); the lifestyle of obese and underweight never smokers differed less from reference.
Heavy smokers (referred as smokers in this section) were observed to be more likely to have an
unfavourable behaviour with respect to almost all modifiable lifestyle proxy factors, regardless
of BMI. In contrast, physical inactivity was the only lifestyle factor that showed an association
with being never smoker, except for hazardous alcohol intake in male obese never smokers.
The association with the lifestyle factors was shown to be stronger in smokers compared to
never smokers. Smokers of both sexes (except for heavy smoking obese women) were most
likely to have a high alcohol intake.
The results for smokers by the investigated BMI categories are described in depth as follows.
Male normal-weight and obese smokers were likely to have an infrequent fruit and vegetable
consumption, low physical inactivity level, and high alcohol intake. For example in men, if an
individual reported a low fruit and vegetable consumption, the relative risk ratio for being an
obese smoker relative to normal-weight never smoker would be expected to be increased (RRR
1.69 [1.30;2.21]) compared to an individual having a high fruit and vegetable consumption. In
underweight smoking men, significant associations were found for physical inactivity and high
Fig 1. Prevalence of smokers by status additionally stratified by BMI for heavy and never smokers SHS 2012.Men n = 35,880 (missing n = 2,949) and
women n = 44,142 (missing n = 2,604). BMI (Body Mass Index, kg/m2): underweight <18.5, normal-weight!18.5–<25, overweight!25–<30, obesity!30;
Smoking status: never, former, light (1–9 cigarettes per day), moderate (10–19), heavy smoker (>19); SHS: Swiss Health Survey; Results are weighted
according to the general population of Switzerland.
doi:10.1371/journal.pone.0148563.g001
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Table 3. Lifestyle of obese and/or heavy smokers by sex, multinomial logistic regression: reference group normal-weight never smokers (adjusted
for sociodemographic factors, age, and survey), weighted according to the general population of Switzerland.
Normal-weight /
Heavy smokers
Obese / Never
smokers
Obese / Heavy
smokers
Underweight /
Never smokers
Underweight / Heavy
smokers
RRR (95% CI) RRR (95% CI) RRR (95% CI) RRR (95% CI) RRR (95% CI)
Men
Fruits and vegetables
Daily 1 1 1 1 1
< Daily 1.82 (1.62;2.05) 1.18 (0.99;1.41) 1.69 (1.30;2.21) 1.21 (0.74;1.98) 1.85 (0.86;3.96)
Physical activity, leisure
> 2 1 1 1 1 1
1 to 2 1.34 (1.16;1.56) 1.23 (0.99;1.52) 1.34 (0.95;1.91) 0.91 (0.52;1.60) 1.11 (0.47;2.62)
Days per week
None 2.91 (2.50;3.37) 1.54 (1.24;1.89) 3.31 (2.38;4.62) 1.29 (0.72;2.30) 3.35 (1.43;7.87)
Alcohol*
Low 1 1 1 1 1
Moderate 3.35 (2.59;4.35) 1.18 (0.75;1.86) 2.15 (1.29;3.60) 1.06 (0.20;5.55) 5.33 (1.59;17.87)
High 4.75 (3.58;6.31) 2.00 (1.23;3.25) 4.29 (2.60;7.07) 0.24 (0.03;1.76) 6.83 (2.37;19.68)
Missing 1.55 (1.20;2.00) 1.36 (0.83;2.22) 1.16 (0.65;2.10) 1.83 (0.53;6.27) 0.62 (0.17;2.18)
Education
Tertiary 1 1 1 1 1
Secondary II 2.04 (1.79;2.33) 1.74 (1.43;2.11) 2.86 (2.06;3.96) 1.93 (1.17;3.20) 6.97 (2.87;16.94)
Mandatory 2.19 (1.79;2.69) 2.67 (2.02;3.52) 3.26 (2.13;4.99) 3.53 (1.77;7.05) 11.67 (3.94;34.61)
Nationality
Swiss 1 1 1 1 1
Foreign 1.43 (1.23;1.67) 1.60 (1.25;2.05) 1.51 (1.08;2.13) 1.19 (0.66;2.12) 1.11 (0.44;2.82)
Language region**
German 1 1 1 1 1
French 1.01 (0.89;1.15) 0.88 (0.73;1.07) 0.73 (0.55;0.99) 1.31 (0.77;2.23) 1.24 (0.62;2.48)
Italian 0.83 (0.66;1.04) 1.07 (0.80;1.44) 1.00 (0.64;1.55) 1.41 (0.67;2.95) 0.81 (0.27;2.45)
Survey
1992 1 1 1 1 1
1997 1.03 (0.86;1.23) 1.19 (0.84;1.70) 1.10 (0.72;1.69) 1.83 (0.79;4.21) 0.58 (0.22;1.52)
2002 0.86 (0.72;1.03) 1.58 (1.13;2.22) 1.19 (0.79;1.79) 2.31 (0.99;5.39) 0.81 (0.35;1.90)
2007 0.60 (0.49;0.73) 2.12 (1.53;2.94) 0.95 (0.61;1.48) 1.26 (0.51;3.08) 0.40 (0.13;1.25)
2012 0.47 (0.39;0.58) 2.54 (1.85;3.48) 1.15 (0.76;1.73) 1.38 (0.58;3.28) 0.52 (0.18;1.50)
Age 1.00 (1.00;1.00) 1.04 (1.03;1.04) 1.02 (1.01;1.02) 0.97 (0.95;0.99) 0.97 (0.95;1.00)
n 2538 1037 434 121 66
Women
Fruits and vegetables
Daily 1 1 1 1 1
< Daily 2.48 (2.19;2.80) 0.96 (0.84;1.10) 1.71 (1.22;2.40) 1.14 (0.98;1.33) 1.91 (1.42;2.56)
Physical activity, leisure
> 2 1 1 1 1
1 to 2 0.86 (0.73;1.02) 1.01 (0.85;1.21) 0.90 (0.54;1.51) 0.96 (0.80;1.15) 0.92 (0.59;1.44)
Days per week
None 1.75 (1.49;2.06) 1.55 (1.32;1.83) 2.18 (1.38;3.43) 1.29 (1.08;1.54) 2.02 (1.33;3.08)
Alcohol*
Low 1 1 1 1 1
(Continued)
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risk alcohol intake, despite the small stratum size and therefore wide confidence intervals.
Female normal-weight and underweight smokers were likely to have an unfavourable behav-
iour in all three lifestyle factors. Obese smoking women were more likely to have infrequent
fruit and vegetable consumption and high alcohol intake. In contrast to men, women who
smoked and/or were underweight or obese were more likely to be physically inactive.
Only a selection of the smoking/BMI combination groups is shown. To briefly summarize
the results for the remaining 14 outcome categories, we found that individuals in these catego-
ries were less likely to have low fruit and vegetable consumption, high alcohol intake, and phys-
ical inactivity, compared to those individuals in the categories with heavy smoking and
extreme BMI (not shown). Only overweight heavy smokers showed similar poor behaviour in
the three lifestyle variables investigated. In addition, we observed that the lifestyle tended to
deteriorate, the more an individual smoked.
Socio-demographic adjustment variables were strongly associated with the combination of
heavy smoking and obesity or underweight. In general, individuals with lower educational level
were more likely to have an extreme BMI and being a smoker. However, this association was
reversed in underweight women. Male foreign nationals were more likely to be normal-weight
or obese smokers and obese never smokers, respectively. Being female Swiss national was
Table 3. (Continued)
Normal-weight /
Heavy smokers
Obese / Never
smokers
Obese / Heavy
smokers
Underweight /
Never smokers
Underweight / Heavy
smokers
RRR (95% CI) RRR (95% CI) RRR (95% CI) RRR (95% CI) RRR (95% CI)
Moderate 3.50 (2.76;4.43) 0.81 (0.53;1.24) 0.55 (0.22;1.39) 1.07 (0.70;1.63) 3.42 (2.06;5.69)
High 5.51 (3.71;8.20) 0.83 (0.40;1.72) 2.19 (0.64;7.49) 0.91 (0.39;2.08) 5.90 (2.54;13.68)
Missing 1.47 (1.14;1.90) 1.05 (0.76;1.46) 0.59 (0.18;1.94) 0.95 (0.69;1.32) 1.72 (0.92;3.22)
Education
Tertiary 1 1 1 1
Secondary II 1.91 (1.59;2.28) 1.78 (1.44;2.19) 1.83 (1.04;3.24) 0.78 (0.66;0.93) 1.51 (0.96;2.37)
Mandatory 2.07 (1.67;2.57) 3.43 (2.73;4.30) 4.28 (2.33;7.84) 0.69 (0.54;0.87) 1.62 (0.95;2.79)
Nationality
Swiss 1 1 1 1 1
Foreign 0.75 (0.62;0.90) 1.37 (1.15;1.65) 0.67 (0.40;1.13) 0.69 (0.55;0.87) 0.63 (0.39;1.00)
Language region**
German 1 1 1 1 1
French 1.30 (1.14;1.47) 0.84 (0.73;0.96) 0.86 (0.60;1.23) 1.28 (1.10;1.50) 1.76 (1.30;2.39)
Italian 0.97 (0.79;1.19) 0.68 (0.55;0.85) 0.79 (0.43;1.43) 1.58 (1.26;1.99) 0.94 (0.58;1.54)
Survey
1992 1 1 1 1 1
1997 1.23 (1.03;1.47) 1.37 (1.09;1.74) 2.56 (1.32;4.97) 0.81 (0.65;1.02) 1.28 (0.81;2.01)
2002 1.01 (0.84;1.21) 1.58 (1.26;1.99) 2.31 (1.22;4.36) 0.88 (0.71;1.10) 1.03 (0.66;1.63)
2007 0.93 (0.76;1.13) 1.84 (1.46;2.31) 1.90 (0.96;3.75) 0.77 (0.61;0.96) 0.93 (0.56;1.54)
2012 0.56 (0.46;0.70) 2.07 (1.66;2.59) 2.09 (1.05;4.15) 0.93 (0.75;1.15) 0.50 (0.30;0.82)
Age 0.98 (0.97;0.98) 1.03 (1.02;1.03) 0.99 (0.98;1.00) 0.98 (0.97;0.98) 0.97 (0.96;0.98)
n 2085 1980 227 1347 313
*Cut-offs: men <40g and <60g and women <20g and <40g of alcohol per day;
**German included Romansh; results shown only for selected combinations of BMI and smoking status.
Missing: BMI n = 1258, smoking status n = 4382, fruits and vegetables n = 1571, physical activity n = 3555, alcohol n = 4966.
doi:10.1371/journal.pone.0148563.t003
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associated with being normal-weight smoker or underweight never smoker, whereas foreign
nationals were more likely to be obese never smokers. A significant impact of language region
was observed mainly in women. Compared to women living in the German speaking part,
women from the French and Italian speaking region were more likely to be underweight and
less likely to be obese. Moreover, those from the French speaking part were more likely to be
underweight smokers.
A decrease in the prevalence of heavy smokers between 1992 and 2012 was observed in
those with normal-weight, especially in men (Table 3). Furthermore, the results suggest that
the prevalence of the combination of heavy smoking with underweight and obesity changed in
women only; it increased in female obese heavy smokers and decreased female underweight
heavy smokers. The prevalence of obese never smokers increased in both sexes.
Discussion
Main results
In this study, we investigated how heavy smoking and extreme BMI as well as the combination
of both were associated with other NCD risk factors. Heavy smokers were more likely to have a
poor diet, high alcohol intake and low level of physical activity than obese or underweight indi-
viduals. While the prevalence of smoking decreased over time in combination with normal-
weight, it increased in combination with obesity in women.
Clustering of lifestyle factors
In line with our results, studies on clustering effects of unfavourable lifestyle factors in adults
emphasise the role of smoking as driving factor [11,26]. The association of smoking was
observed to be particularly strong with high alcohol intake [27]. Clustering effects of unhealthy
lifestyles were reported to be more likely in individuals with a low educational level [12,13]. In
our study, this was consistently shown in men, i.e. smoking and high/low BMI were associated
with low educational level. In contrast, this association was reversed in women, i.e. under-
weight was associated with high educational level. Others showed that men and especially
women with higher socioeconomic status were more concerned about their body weight and
made more efforts to control it [28,29]. Interestingly, unhealthy behaviours were found to clus-
ter stronger than healthy behaviours [30]. We are not aware of other studies performing a com-
parative analysis of the lifestyle of heavy smokers, obese, and underweight individuals.
However, a study looking at age-specific lifestyle risk factors for obesity observed that young
and middle-aged obese adults were frequently physically inactive; in older obese adults, poor
eating habits were identified as an additional risk factor [31]. So far, much less has been
reported about the lifestyle of underweight individuals because in developed countries the
prevalence and, therewith, public health relevance is lower compared to obesity [32]. Reverse
causation due to smoking and pre-existing disease has to be taken into account when studying
health effects of underweight, e.g. mortality [33,34]. Our findings suggest that underweight
never smoking women were at risk for physical inactivity, which could be either an attitude or
indicating an underlying disease.
Prevalence trends
We found that the prevalence of normal-weight heavy smokers decreased in Switzerland
between 1992 and 2012 in both sexes. Across Europe, considerable differences in smoking
prevalence exist; eastern and low income countries as well as countries with less advanced
tobacco control policies have highest smoking prevalence [35]. An estimation of smoking
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prevalence worldwide showed that it is especially high among men in South, Southeast, and
East Asia, e.g. more than 50% in Russia and Indonesia [14]. Our results show that in Switzer-
land the decrease in smoking prevalence mainly occurred in those with normal BMI; amongst
obese individuals, the smoking prevalence stagnated (men) or even increased (women). This
suggests that clustering of unhealthy lifestyles persisted or accentuated over time in part of the
population, low socioeconomic status was shown to be an important factor explaining this
effect [36–38].
Public health relevance
Our results support the notion of smoking as a key determinant of an unhealthy lifestyle. In
light of the ongoing clustering of smoking with other unfavourable lifestyle factors, efforts
aimed at reducing tobacco use in the population need to be intensified. This is supported by
the recent trends of cancer death in women; in Europe lung cancer is the leading cause, thus
superseded breast cancer [39]. In Switzerland, previous efforts led to a decrease of the smoking
prevalence in general, but a decrease was only observed in the normal-weight part of the popu-
lation. Because obese and underweight smokers have a particularly problematic health risk pat-
tern, a decrease in smoking prevalence would be even more important than in normal-weight
individuals. In Switzerland, obesity contributes to an excess in death of about 7% and costs of 8
billion Swiss Francs; smoking of about 12% and 10 billion Swiss Francs [40–43]. As shown by
Li et al. [44], non-smoking and maintaining healthy body weight are the lifestyles with the
greatest potential to reduce the number of premature deaths and should therefore be the main
target of public health strategies improving lifestyle.
Strengths and Limitations
The SHS is a comprehensive survey collecting data on major lifestyle risk factors through a
large representative sample of the general population. The large sample size allowed for the
analysis of lifestyle factors in defined risk groups based on BMI category and smoking status.
Potential confounders were included in the analysis, especially education. The repeated assess-
ment (the SHS is conducted every 5 years) provided insights into changes over time in preva-
lence of the considered risk groups.
The participation rate decreased over the 5 SHS from 71% in 1992 to 53% in 2012 [17,45].
Two measures were implemented to account for this decrease in participation rate. First, in
2012 efforts were intensified to include persons having no landline telephone number available
in the database, by sending out prepaid answer postcards to obtain further contact information
to conduct the telephone interview. Second, analysis of the SHS data has to be done by applying
weighting according to the general population of Switzerland. Nevertheless, it is likely that par-
ticipants tend to be healthier than non-participants [46]. Self-reporting on lifestyle variables
made non-differential misclassification of those variables more likely. Only a short question-
naire was used to evaluate fruit and vegetable consumption, alcohol intake and physical activity
[47,48]. To draw conclusions, for example on the adherence to the “5-a-day” recommendation,
more detailed information would be needed. The assessment of fruit and vegetable consump-
tion was even aggravated by the fact that the collected information changed over the course of
surveys and, therefore, it was necessary to use a dichotomized variable. BMI was shown to be
underestimated in obese and overestimated in underweight [49]. For underweight, effect esti-
mates were imprecise as strata size was small. Finally, due to the cross-sectional study design
no causal relationships can be inferred.
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Conclusion
Both heavy smoking and BMI extremes were associated with unhealthy general lifestyle, ren-
dering them particularly vulnerable for NCDs. However, the relationship was stronger for
heavy smoking than for obesity and underweight. Smoking prevention measures should pay
special attention to improvement of general lifestyle and co-occurrence with obesity and
underweight. Future research in this area should focus on how lifestyle factors are interacting
in the development of NCDs, i.e. looking at lifestyle patterns rather than single lifestyle risk fac-
tors. In addition, investigating the role of lifestyle factors using a life course approach may help
to deepen the understanding of their association with NCDs.
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S1 Table. Data Collection on Height, Weight, and Smoking Status; Swiss Health Survey 1992 to 2012. 
Height and weight 
Nr. Fragen Thema Modul 1992 1997 2002 2007 2012 Quelle / Bemerkungen 
23.00 
 
WIEDER AN ALLE 
 
Können Sie mir sagen, wie gross Sie ohne Schuhe sind? 
--------------------------------------------- 
- Zentimeter (3-stellig)  ............................................ _ _ _ 
--------------------------------------------- 
- Weiss nicht .............................................................. (-1) 
- Keine Antwort .......................................................... (-2) 
Gesundheitszustand 
Körpermasse 
TGEZU01b 
Kern 1 1 1 1 1 IGIP tel. 54.00 
 
SGB07: TGEZU01a entfernt, 
da überflüssig. 
 
23.10 
 
Und wie schwer sind Sie ohne Kleider? 
 
BEI SCHWANGEREN FRAUEN (22.00 = 1):  
Wie schwer sind Sie am Anfang von der Schwangerschaft gewesen? 
--------------------------------------------- 
- Kilos (3-stellig)  ...................................................... _ _ _  
--------------------------------------------- 
- Weiss nicht .............................................................. (-1) 
- Keine Antwort .......................................................... (-2) 
Gesundheitszustand 
Körpermasse 
TGEZU02b 
Kern 1 1 1 1 1 IGIP tel. 55.00 
 
SGB07: TGEZU02a entfernt, 
da überflüssig 
Smoking 
39.00 
 
Rauchen Sie, wenn auch nur selten? 
---------------------------------------------- 
- Ja .................................................................................. 1 
- Nein .............................................................................. 2 weiter zu 39.20 
---------------------------------------------- 
- Keine Antwort.................... ......................................... (-2) weiter zu 39.20 
Tabakkonsum 
TTAKO01 
Kern 1 1 1 1 1 Anal. IGIP tel. 28.00 
39.01 
 
Rauchen Sie täglich? 
---------------------------------------------- 
- Ja .................................................................................. 1 
- Nein .............................................................................. 2 
---------------------------------------------- 
- Keine Antwort.................... ......................................... (-2) 
Tabakkonsum 
TTAKO21 
Kern 0 0 0 1 1 EHIS angepasst 
 
39.10 
 
Was rauchen Sie? 
INT: Vorlesen! 
--------------------------------------------- 
- Zigaretten .............................. Ja=1 Nein=2 Keine Antwort=(-2) 
- Zigarren ................................ Ja=1 Nein=2 Keine Antwort=(-2) 
- Cigarillos ............................... Ja=1 Nein=2 Keine Antwort=(-2) 
- Pfeife ..................................... Ja=1 Nein=2 Keine Antwort=(-2) 
- Wasserpfeife ......................... Ja=1 Nein=2 Keine Antwort=(-2) 
Tabakkonsum 
 
 
TTAKO02a 
TTAKO02b 
TTAKO02c 
TTAKO02d 
TTAKO02e 
Kern 1 1 1 1 1 IGIP tel. 28.10 
 
SGB07 mit TTAKO02e 
ergänzt 
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39.11 
 
 
PERSONEN, DIE ZIGARETTEN RAUCHEN (TTAKO02A/39.10=1) 
 
Wieviele Zigaretten rauchen Sie im Durchschnitt pro Tag? 
INT: 1 Paket = 20 Zigaretten / 1/2Paket =10 Zigaretten 
--------------------------------------------- 
- Zigaretten (2-stellig) ...................................................._ _ 
- Weniger als 1 pro Tag ..................................................00 
--------------------------------------------- 
- Keine Antwort ............................................................. (-2) 
Tabakkonsum 
TTAKO03 
Kern 1 1 1 1 1 IGIP tel. 28.11 
39.12 
 
 
PERSONEN, DIE ZIGARREN RAUCHEN (TTAKO02B/39.10=1) 
 
Wie viele Zigarren rauchen Sie im Durchschnitt pro Tag? 
--------------------------------------------- 
- Zigarren (2-stellig) ......................................................._ _ 
- Weniger als 1 pro Tag ..................................................00 
--------------------------------------------- 
- Keine Antwort ............................................................. (-2) 
Tabakkonsum 
TTAKO04 
Kern 1 1 1 1 1 IGIP tel. 28.12 
Nr. Fragen Thema Modul 1992 1997 2002 2007 2012 Quelle / Bemerkungen 
39.13 
 
 
PERSONEN, DIE CIGARILLOS RAUCHEN (TTAKO02C/39.10=1) 
 
Wie viele Cigarillos rauchen Sie im Durchschnitt pro Tag? 
--------------------------------------------- 
- Cigarillos (2-stellig) ......................................................_ _ 
- Weniger als 1 pro Tag ..................................................00 
--------------------------------------------- 
- Keine Antwort ............................................................. (-2) 
Tabakkonsum 
TTAKO05 
Kern 1 1 1 1 1 IGIP tel. 28.13 
39.14 
 
 
PERSONEN, DIE PFEIFE RAUCHEN (TTAKO02D/39.10=1) 
 
Wie viele Pfeifen rauchen Sie im Durchschnitt pro Tag? 
--------------------------------------------- 
- Pfeifen (2-stellig) ........................................................._ _ 
- Weniger als 1 pro Tag ..................................................00 
--------------------------------------------- 
- Keine Antwort ............................................................. (-2) 
Tabakkonsum 
TTAKO06 
Kern 1 1 1 1 1 IGIP tel. 28.14 
Nr. Fragen Thema Modul 1992 1997 2002 2007 2012 Quelle / Bemerkungen 
39.20 
 
NUR NICHTRAUCHER/INNEN  (+KA) (TTAKO01/39.00=2, -2).  
RAUCHER/INNEN WEITER ZU FRAGE 39.30 
 
Haben Sie je regelmässig während mehr als 6 Monaten geraucht? 
--------------------------------------------- 
- Ja .................................................................................. 1 
- Nein .............................................................................. 2 weiter zu 39.50 
--------------------------------------------- 
- Keine Antwort ............................................................. (-2) weiter zu 39.50 
Tabakkonsum 
TTAKO07 
Kern 1 1 1 1 1 IGIP tel. 28.30  
 
  
S2 Table. Distribution of selected BMI category and Smoking Status Combinations, SHS 1992 to 2012, *weighted according to the Swiss general 
population. 
 
 
 Men  Women 
n %*  n %* 
Smoking - BMI - 
combination 
 
 
  
 
Normal-weight/ Never 
smoker 
 
9106 25.4 
 
16850 38.5 
Normal-weight/ Heavy 
smoker 
 
2595 6.8 
 
2131 4.2 
Obese/ Never smoker  1124 3.0  2108 4.6 
Obese/ Heavy smoker  441 1.2  234 0.4 
Underweight/ Never smoker  273 0.9  1651 4.0 
Underweight/ Heavy smoker  69 0.2  328 0.6 
Total 
 37152 100.00  45395 100.00 
 
  
S3 Table. Distribution of fruit and vegetable consumption, physical activity, and alcohol intake, SHS 1992 to 2012, *weighted according to the 
Swiss general population. 
 
 
 Men  Women 
n %*  n %* 
Fruit and vegetable 
consumption 
 
  
  
 
Daily  19022 50.9  32409 70.5 
< Daily  18875 49.1  13698 29.5 
Physical activity, leisure time, 
days per week 
 
  
 
  
>2  11068 30.8  10449 23.7 
1 to 2  13501 37.2  15605 35.0 
None  12175 32.0  19222 41.3 
Alcohol intake 
      
Low  33465 86.0  42180 90.1 
Moderate  1622 4.0  1531 3.1 
High  1343 3.2  468 1.0 
Missing  2399 6.8  2567 5.8 
Total 
 37152 100.00  45395 100.00 
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Continuous Outcome Logistic Regression for
Analyzing Body Mass Index Distributions
Tina Lohse Sabine Rohrmann David Faeh Torsten Hothorn
Abstract
Body Mass Index (BMI) categories are used to monitor weight status and associated
health risks in populations. Binary or multinomial logistic regression models are com-
monly applied in this context but are only applicable to BMI values categorized within
a small set of defined ad hoc BMI categories. This approach precludes comparisons with
studies and models based on different categories, which renders meta analyses difficult.
In addition, ad hoc categorization of BMI values prevents the estimation and analysis of
the underlying continuous BMI distribution and leads to information loss. As an alterna-
tive to multinomial regression following ad hoc categorization, we propose a continuous
outcome logistic regression model for the estimation of a continuous BMI distribution.
Parameters of interest, such as odds ratios for specific categories, can be extracted from
this model post hoc in a general way. A continuous BMI logistic regression that describes
BMI distributions avoids the necessity of ad hoc and post hoc category choice and sim-
plifies between-study comparisons and pooling of studies for joint analyses. The method
was evaluated empirically using data from the Swiss Health Survey.
Keywords: Distribution regression, transformation model, conditional distribution, odds ratio,
smoking.
Body mass index (BMI) is an anthropometric measure that is relatively easy to capture in
epidemiological studies. Thus, it is widely used for describing underweight, overweight, and
obesity (Wells and Fewtrell 2006; Ng et al. 2014). The most prominent standard BMI cate-
gories underweight, normal weight, overweight, and obesity as defined by the World Health
Organization (WHO, World Health Organization 2000) are commonly applied to ensure com-
parability and reproducibility of statistical analyses across epidemiological studies (Flegal
et al. 2013, 2014). Such international standards are important for the communication of sci-
entific results, for risk factor assessment and monitoring in populations, and for providing
information to the general public. However, categorization of BMI values inevitably leads to
information loss because an individual’s weight and height can be measured precisely using
simple tools (Wells and Fewtrell 2006), but this precision is lost in statistical analyses by such
an ad hoc categorization (Altman and Royston 2004). The most important problem, how-
ever, is the lack of comparability across studies that rely on different categorization schemes.
Even more troublesome is the problem of comparability of studies and findings over time
because the WHO categories can be expected to be updated to better reflect contemporary
BMI distributions. Only roughly half of the studies published up to 2000 that used BMI as a
risk factor for death used the WHO categories; the other half relied on a variety of different
alternative schemes (Flegal et al. 2013, 2014). The same problem occurs when the primary
interest in a statistical analysis is the comparison of BMI distributions between different risk
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groups. In this latter situation, we advocate post hoc categorization of model outputs instead
of ad hoc categorization of BMI measurements to better combine measurement precision, ease
of communication, comparability, and reproducibility. Specifically, we propose that statistical
analyses should be based on precise BMI measurements without ad hoc categorization, and
then parameters and interesting contrasts thereof should then be categorized post hoc. Such
results would be interpretable and universally comparable between studies using any type of
category.
Conceptually, the traditional approaches to the analysis of BMI can be understood as re-
gression models for the conditional distribution of BMI, given exposure, sex, and covariates
(Chang and Christakis 2003; Chiolero et al. 2007; John et al. 2005; Clair et al. 2011; Mackay
et al. 2013; Dare et al. 2015; Mead et al. 2016). For example, restricting the only exposure
variable to smoking in the following, the generic logistic regression model (Agresti 2013) for
BMI, conditional on smoking status, sex, and covariates x of the form
logit(P(BMI ≤ b | smoking, sex,x)) = r(b | smoking, sex,x) (1)
can be used to understand the impact of these variables on the distribution of BMI. After
ad hoc categorization, only the conditional distribution of BMI at the corresponding cut-
off points b can be evaluated. This also corresponds to a specific parameterization of the
regression function r. The core idea of continuous outcome logistic regression is to model
the entire conditional distribution of BMI for all reasonable BMI values simultaneously. This
requires that the parameterization of the regression function r is a smooth and monotonically
increasing function of b. Sex, smoking status, and covariates x then have an impact on
the regression function r and thus on conceptually all moments (mean, variance, skewness,
kurtosis, etc.) of the conditional continuous BMI distribution.
The interpretation of parameters and contrasts thereof in this more general model is as sim-
ple as in models based on specific categories. For example, the difference between r(b |
former smoker, female,x) and r(b | never smoker, female,x) is the log-odds ratio of the event
BMI ≤ b of former female smokers compared to females who never smoked, both of which
share the same covariate status x. After traditional ad hoc categorization, this odds ratio can
only be evaluated for the small set of cut-off points b that define the categories. For continu-
ous outcome logistic regression, the odds ratio can be evaluated for all potential BMI values
b > 0, which allows the associations for different categorization schemes to be interpreted
post hoc. This feature ensures comparability and reproducibility independent of any ad hoc
choice of categories.
The continuous outcome logistic regression model can be estimated by maximum likelihood for
BMI measurements recorded at different scales. The likelihood contribution of an individual
with a BMI value in the interval (
¯
b, b¯] is simply the probability, in light of some specific
regression function r, of observing a BMI within this interval (Lindsey 1996)
P(
¯
b < BMI ≤ b¯ | smoking, sex,x) (2)
= P(BMI ≤ b¯ | smoking, sex,x)− P(BMI ≤
¯
b | smoking, sex,x)
= expit(r(b¯ | smoking, sex,x))− expit(r(
¯
b | smoking, sex,x)).
The BMI measurement (
¯
b, b¯] can be a narrow numeric interval based on precise measurements
of height and weight, or a wide interval corresponding to some standard or non-standard cat-
egorization scheme. Thus, continuous outcome logistic regression is applicable to studies that
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implement different BMI measurement scales or categorization schemes, or even a mixture of
those. The procedure thus directly addresses the conceptual problem of lack of comparability
between different studies.
The aim of our study was to propose a continuous outcome logistic regression model for BMI
that is independent of both the BMI measurement scale and cut-offs used for ad hoc cate-
gorization, which would allow tailored categorized parameters and contrasts to be extracted,
compared, and communicated post hoc. We expected the model to be insensitive to the BMI
measurement scales, in light of both the estimated conditional BMI distributions and the
covariate model parameters. We evaluated this hypothesis empirically by analyzing the asso-
ciation of smoking status and BMI using data from the Swiss Health Survey 2012 (Bundesamt
fu¨r Statistik 2013) while controlling for important covariates, such as age, alcohol intake, diet,
physical activity, and socio-economic variables. We compared models fitted to a cascade of
increasingly precise BMI values, starting with the four WHO categories and ending with the
“exact” BMI values. This allowed an understanding of the impact of the measurement scale
on the resulting models. We also expected the results of the novel continuous outcome logistic
model for BMI to be comparable to previously reported associations of smoking and BMI,
and evaluated this hypothesis for the Swiss Health Survey 2012.
Methods
Population for Empirical Evaluation
The Swiss Health Survey (SHS) is a population-based cross-sectional survey. Since 1992, it
has been conducted every five years by the Swiss Federal Statistical Office (Bundesamt fu¨r
Statistik 2013). For this study, we restricted the sample from the 2012 survey to 16,427 in-
dividuals aged between 18 and 74 years. Height and weight were self-reported by telephone
interview. Records with extreme values of height or weight were excluded (highest and lowest
percentile by sex). Smoking status was categorized into never smoked, former smokers, light
smokers(1 − 9 cigarettes per day), moderate smokers(10 − 19), and heavy smokers (> 19).
Individuals who never smoked stated that they did not currently smoke and never regularly
smoked for longer than a six-month period; former smokers had quit smoking but had smoked
for more than 6 months during their life. One cigarillo or pipe was counted as two cigarettes,
and one cigar was counted as four cigarettes. The following adjustment variables were in-
cluded: fruit and vegetable consumption, physical activity, and alcohol intake. Information
on the number of days per week fruits and vegetables were consumed was available. We chose
to categorize as close to the “5-a-day” recommendation as possible (World Health Organi-
zation 2003). Fruit and vegetable consumption was combined in one binary variable that
comprised the information on whether both fruits and vegetables were consumed daily or
not. The variable describing physical activity was defined as the number of days per week a
subject started to sweat during leisure time physical activity and was categorized as > 2 days,
1 − 2 days, or none. Alcohol intake was included using the continuous variable grams per
day. Education was included as highest degree obtained and was categorized as mandatory
(International Standard Classification of Education, ISCED 1-2), secondary II (ISCED 3-4),
or tertiary (ISCED 5-8) (UNESCO Institute for Statistics 2012). Nationality had the two cat-
egories Swiss and foreign. Language region reflecting cultural differences within Switzerland
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was categorized as German/Romansh, French, or Italian.
Models for BMI Distributions
Binary logistic regression, ordered, and unordered polytomous logistic regression (Agresti
2013) were previously applied to the analysis of BMI distributions based on ad hoc categorized
BMI values. We will review the corresponding parameterizations and compare the model
parameters in the common framework of model (1) before introducing the novel continuous
outcome logistic regression for the analysis of BMI distributions.
Binary Logistic Regression For a binary outcome, such as non-obesity vs. obesity (BMI30 =
I(BMI ≤ 30)), the regression function is defined for non-obese individuals only
r(30 | smoking, sex,x) = α30 + γsmoking:sex + x
⊤β,
with intercept α30, main and interaction parameters γ of smoking and sex, and re-
gression coefficients or covariate parameters β. This model evaluates the conditional
distribution function for BMI only at b = 30 . Note that a change of the BMI cut-off
point b leads to a different model and thus different parameter estimates for all param-
eters αb, γ, and β. Such models have been reported for b = 25 or b = 30 Mackay et al.
(2013); Dare et al. (2015).
Ordered Polytomous Logistic Regression This model is also known as proportional odds
logistic regression for an ordered categorical outcome, such as the WHO categories
(World Health Organization 2000) underweight (BMI18.5 = I(BMI ≤ 18.5)), normal
weight (BMI(18.5,25] = I(18.5 < BMI ≤ 25)), overweight (BMI(25,30] = I(25 < BMI ≤
30)), and obese (BMI > 30). For these four categories, the model is defined by three
category-specific regression functions
r(18.5 | smoking, sex,x) = α18.5 + γsmoking:sex + x
⊤β
r(25 | smoking, sex,x) = α(18.5,25] + γsmoking:sex + x
⊤β
r(30 | smoking, sex,x) = α(25,30] + γsmoking:sex + x
⊤β
or, in more compact notation, by r(b | smoking, sex,x) = α(b)+γsmoking:sex+x
⊤β with
intercept function
α(b) =


α18.5 b ≤ 18.5
α(18.5,25] 18.5 < b ≤ 25
α(25,30] 25 < b ≤ 30.
(3)
The parameters γ and β are the same for all three regression functions and can be in-
terpreted as category-independent log-odds ratios as a consequence of the proportional
odds assumption on these parameters. The intercept function increases monotonically.
Ordered polytomous logistic regression can be understood as a series of binary logistic
regression models where only the intercept is allowed to change with increasing BMI
values at cut-off points chosen ad hoc. Self-reported BMI values using the WHO criteria
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have been analyzed by such a model in Chang and Christakis (2003). The BMI distribu-
tion of children categorized at marginal percentiles has been analyzed by a proportional
odds model in (Mead et al. 2016).
Unordered Polytomous Logistic Regression Multinomial logistic regression is equiva-
lent to polytomous logistic regression for an unordered outcome and is a generalization
of the proportional odds model as it allows for category-specific parameters γ(b) and
β(b) in the regression function
r(b | smoking, sex,x) = α(b) + γ(b)smoking:sex + x
⊤β(b)
for b ∈ {18.5, 25, 30}. The model can be used to test the proportional odds assumption,
i.e., γ ≡ γ(b) and β ≡ β(b) for all b ∈ {18.5, 25, 30}. Typically, the model is intro-
duced as a model of the conditional density by the relationship between density and
distribution function for discrete variables (as in (2)). This model is very popular for
the analysis of BMI-related outcomes (Chiolero et al. 2007; John et al. 2005; Clair et al.
2011).
The novel continuous outcome logistic regression model can be viewed as a generalization of
the above-introduced models from discrete to continuous outcomes. BMI is understood as
a conceptually continuous variable, regardless of the scale of the actual BMI measurements.
The most important aspect here is a smooth and monotonically increasing intercept function
α(b). In an unconditional model for the marginal BMI distribution
logit(P(BMI ≤ b)) = r(b) = α(b),
, such an intercept function can model arbitrary BMI distribution functions by the term
expit(α(b)). This essentially removes the need to specify a strict parametric distribution,
such as the normal, for BMI. Because of a potential impact of both smoking and sex of the
individual on the entire distribution, we stratify this intercept function with respect to these
two variables, i.e., one specific intercept function is dedicated to each combination of smoking
and sex:
logit(P(BMI ≤ b | smoking, sex)) = r(b | smoking, sex) = α(b)smoking:sex.
To facilitate model interpretation, we assume that regression coefficients β of the remaining
covariates are constant across the entire BMI distribution in our final model
logit(P(BMI ≤ b | smoking, sex,x)) = r(b | smoking, sex) (4)
= α(b)smoking:sex + x
⊤β.
The regression coefficients β are log-odds ratios of all possible events BMI ≤ b, b > 0. The
interpretation of the parameters β is the same in logistic regression, proportional odds regres-
sion, and the novel continuous BMI logistic regression (4). This model can be understood as
a joint model of all possible binary logistic regression models for the outcomes BMI ≤ b with
b > 0 under two constraints: (1) the sex- and smoking-level-specific intercept is not allowed
to jump abruptly and increases for increasing cut-off points b; (2) the regression coefficients β
are held constant as b increases. Instead of restricting our attention to specific binary logistic
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regression models defined by some cut-off points chosen ad hoc, we can answer questions
about the odds ratios for all or specific events BMI ≤ b post hoc based on this model.
The interpretation of the sex- and smoking-specific intercept functions, and thus the associa-
tions of smoking and sex with BMI, however, is fundamentally different from the interpretation
of the regression coefficients β. Because we allow the entire BMI distribution to change with
these two variables in more complex ways, there is no simple interaction term γ that captures
these parameters in model (4). However, model (4) allows computation of the log-odds ratios
for some event BMI ≤ b between, for example, female former smokers and females who never
smoked for all x as
r(b | former smoker, female,x)− r(b | never smoked, female,x)
= α(b)former smoker:female − α(b)never smoked:female
In this way, the parameters and contrasts we are interested in are not directly parameterized
in model (4) but nevertheless can be obtained from this model by relatively simple contrasts.
The events BMI ≤ b are not restricted to those of a specific categorization of the BMI
measurements (such as the WHO categories). Due to the smoothness of the underlying
intercept functions, log-odds ratios can be computed for arbitrary BMI values b > 0.
Likelihoods for BMI Models
Because the regression function r is defined for all possible BMI values b in model (4), the
likelihood (2) can be evaluated for all types of intervals (
¯
b, b¯] and also for “exact” BMI values
computed as the ratio of weight and squared height. We distinguished between four different
likelihood contributions corresponding to four different BMI measurement scales.
WHO Categories (WHO) The BMI for each individual was reported in one of the four
WHO categories corresponding to the intervals ≤ 18.5 (underweight), (18.5, 25] (normal
weight), (25, 30] (overweight), > 30 (obese). The likelihood contribution of a normal-
weight individual is thus
P(18.5 < BMI ≤ 25 | smoking, sex,x) =
expit(r(25 | smoking, sex,x))− expit(r(18.5 | smoking, sex,x)).
Other Categories (Int 1) Other studies might have used a different categorization scheme,
e.g., the 21 categories defined by BMI intervals for length two:
≤ 17, (17, 19], (19, 21], . . . , (35, 37], > 37.
An individual with a BMI value between 19 and 21 thus contributes
expit(r(21 | smoking, sex,x))− expit(r(19 | smoking, sex,x))
to the likelihood.
Numeric Intervals (Int 2) With weight measured in kilogram and height in meters, the
BMI is calculated according to its definition as BMI = weight/height2. However, for an
individual 1.75m tall weighting 76kg, all BMI values between 75.5/1.7552 = 24.51 and
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76.5/1.7452 = 25.12 are consistent with this individual due to rounding error. Thus,
this individual contributes
expit(r(25.12 | smoking, sex,x))− expit(r(24.51 | smoking, sex,x))
to the likelihood, which automatically takes the measurement error into account. These
intervals can be expected to be much larger in studies that rely on self-reported weights
and heights.
Exact Measurements (Exact) If extreme precision was used to measure weight and height,
BMI = weight/height2 can be considered an “exact” observation. Because the interval
around this value is very narrow, one can approximate the likelihood contribution by
the density of the conditional BMI distribution
∂expit(r(b | smoking, sex,x))
∂b
(5)
evaluated at the “exact” BMI value.
It is important to note that it is possible to evaluate the likelihood when a mixture of these
different BMI measurement scales is applied to subsets of the individuals. In subject-level
meta analyses, for example, it would be possible to estimate a joint model based on studies
using different BMI categorizations or no categorization at all. From a purely theoretical
point of view, the application of numeric intervals that take rounding error into account (Int
2) is most appropriate. The remaining three procedures must be considered approximate.
Results
Comparison of Conditional BMI Distributions
Comparison of estimated probabilities obtained from the four different likelihoods for model
(4) showed that these probabilities were practically identical. For females and males of all
smoking categories with baseline covariates, the estimated conditional BMI distribution eval-
uated at the WHO categories b ∈ {18.5, 25, 30} obtained from model (4) are given in Table 1.
The model was fitted to BMI observations categorized according to the WHO and to a dif-
ferent categorization with intervals of two BMI units (Int 1). Furthermore, numeric intervals
taking rounding error into account (Int 2) and“exact”BMI values were used to estimate model
(4). The approximation of the likelihood by the density was very accurate, as the estimated
probabilities obtained from models estimated from numeric intervals taking rounding error
into account (Int 2) and “exact”BMI values were very close. Differences occurred in the third
decimal place if at all. Slightly larger differences were observed between numeric intervals (Int
2) and intervals obtained by categorization Int 1. The more extreme WHO categorization led
to the largest differences in these estimated probabilities, but the results were still practically
identical.
Comparison of Covariate Associations with BMI
In addition to a comparison of the estimated probabilities, we also compared the proportional
log-odds ratios β among the four BMI likelihoods (Table 2) and did not find relevant dif-
ferences. The approximation of the likelihood based on the density resulted in odds ratios
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Table 1: Conditional Distribution of BMI for WHO Categories. For baseline characteristics x, the probabilities obtained from model
(4) for BMI ≤ 18.5, BMI ≤ 25, and BMI ≤ 30 are given for each combination of smoking and sex of the individual. The model
was fitted using the likelihood (Lik) defined by BMI measurements categorized according to the WHO and according to a different
categorization with intervals of two BMI units (Int 1). Numeric intervals taking rounding error into account (Int 2) and “exact” BMI
values were used to estimate the model parameters. The differences between these four ways of evaluating the likelihood with respect
to the estimated probabilities were marginal.
BMI: ≤ 18.5 ≤ 25 ≤ 30
Sex Smoking Lik.: WHO Int 1 Int 2 Exact WHO Int 1 Int 2 Exact WHO Int 1 Int 2 Exact
Female Never 0.056 0.039 0.043 0.044 0.764 0.735 0.728 0.728 0.943 0.929 0.932 0.932
Former 0.053 0.038 0.043 0.043 0.748 0.717 0.712 0.712 0.941 0.932 0.931 0.931
Light 0.079 0.051 0.062 0.063 0.787 0.759 0.755 0.755 0.968 0.955 0.957 0.957
Medium 0.047 0.042 0.048 0.048 0.768 0.732 0.723 0.723 0.948 0.944 0.942 0.942
Heavy 0.084 0.086 0.071 0.071 0.740 0.705 0.713 0.712 0.946 0.937 0.938 0.939
Male Never 0.003 0.004 0.004 0.004 0.546 0.503 0.507 0.507 0.921 0.907 0.910 0.910
Former 0.000 0.002 0.002 0.002 0.500 0.411 0.405 0.406 0.912 0.887 0.884 0.885
Light 0.000 0.002 0.003 0.003 0.545 0.497 0.497 0.497 0.932 0.918 0.926 0.925
Medium 0.000 0.006 0.005 0.005 0.569 0.522 0.521 0.522 0.932 0.914 0.922 0.922
Heavy 0.006 0.003 0.003 0.003 0.525 0.469 0.462 0.461 0.901 0.881 0.879 0.879
Lohse, Rohrmann, Faeh, Hothorn 9
numerically almost identical to those obtained from numeric intervals that take the rounding
error into account (Int 2). The odds ratios obtained with intervals of Int 1 differed more but
were still negligible. This also applied to the marginally less accurate odds ratios obtained
from models fitted to BMI values categorized according to WHO criteria. It should be noted
that the lengths of the confidence intervals between the four different BMI likelihoods were
in line, which indicated that not only the estimated parameters βˆ but also their estimated
standard errors are comparable among the four approaches.
The large sample size led to almost all odds ratios being significant. Age was associated with
a shift towards larger BMI values, while higher alcohol intake was associated with marginally
reduced BMI. Lower intake of fruits and vegetables as well as less physical activity also indi-
cated a shift to higher BMI values. The BMI distributions of people with a higher education
were shifted to the left compared to those of less well-educated people. The BMI values of
people of the German-speaking part of Switzerland were higher than those of the French- and
Italian-speaking regions.
Impact of Smoking and Sex of the Individuals on BMI Distribution
The estimated conditional BMI distribution for all combinations of smoking and sex were
clearly non-symmetric, and the impacts of smoking and sex of the individual related to changes
in the mean and higher moments (Figure 1). The BMI distribution shifted towards larger
BMI values from males who never smoked to male former smokers. In this case, only the mean
was affected; the shape of the distribution was constant. The BMI distribution of females
who never smoked and female former smokers was similar to those of males. The difference
between the two sexes could not be described by a simple shift because the shapes of the
two distributions clearly differed. In general, the association of smoking and BMI was less
pronounced for females than for males. Compared to the associations of sex (Figure 1), the
smoking associations were much smaller.
We quantified the odds ratios of the smoking association for both sexes for the BMI categories.
Table 3 presents the same information as the distribution functions evaluated with the BMI
categories (gray vertical lines in Figure 1) on the odds ratio scale in a condensed form. The
odds of lower BMI evaluated at BMI ∈ {25, 30} for male former smokers were smaller than
for males who never smoked. The odds ratios for underweight and normal weight (BMI ≤ 25)
and for non-obesity (BMI ≤ 30) increased for both males and females.
For current smokers, the odds ratio patterns that depended on BMI differed between males
and females. All smoking levels were associated with larger odds of being underweight for
females and had a U-shaped pattern. For males, this association was reversed and had an
inverted U-shaped pattern. In the center of the BMI distribution (BMI ≤ 25), the odds ratios
were much closer to 1 for both sexes. The odds ratios for non-obesity (BMI ≤ 30) for females
indicated a trend towards smaller BMI values for current smokers. Except for heavy smokers,
this effect was also found for males.
Discussion
Our study showed that it was possible to analyze and compare BMI distributions in terms
of standard parameters without the need of ad hoc categorization. Continuous BMI logistic
regression, which avoided ad hoc categorization of BMI values, led to deeper insights into
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Table 2: Estimated Proportional Odds Ratios of Covariates. The odds ratios exp(βˆ) along with 95% confidence intervals for the
covariates age (centered at 40 years), education, alcohol intake, fruit and vegetable consumption, physical activity, education, nation-
ality, and region are given for the four ways of evaluating the likelihood of model (4), i.e., , using BMI measurements categorized
according to the WHO and according to a different categorization with intervals of two BMI units (Int 2), numeric intervals taking
rounding error into account (Int 2), and “exact” BMI values.
Likelihood
Covariate WHO Int 1 Int 2 Exact
Age (centered at 40 in y) 0.968 0.966, 0.970 0.969 0.967, 0.971 0.968 0.967, 0.970 0.968 0.967, 0.970
Alcohol intake (g/d) 1.002 0.999, 1.004 1.003 1.001, 1.005 1.003 1.001, 1.004 1.002 1.001, 1.004
Fruit and vegetables
High 1 1 1 1
Low 0.880 0.824, 0.940 0.928 0.874, 0.986 0.929 0.878, 0.983 0.929 0.878, 0.983
Physical activity
High 1 1 1 1
Moderate 0.836 0.774, 0.903 0.850 0.792, 0.912 0.863 0.808, 0.921 0.862 0.808, 0.921
Low 0.695 0.640, 0.756 0.743 0.688, 0.802 0.769 0.716, 0.827 0.769 0.716, 0.826
Education
Mandatory 1 1 1 1
Secondary 1.095 0.992, 1.209 1.252 1.141, 1.373 1.256 1.150, 1.371 1.254 1.149, 1.369
Tertiary 1.604 1.441, 1.786 1.760 1.594, 1.944 1.785 1.625, 1.961 1.781 1.622, 1.956
Nationality
Swiss 1 1 1 1
Foreign 0.785 0.728, 0.848 0.832 0.776, 0.893 0.810 0.758, 0.864 0.809 0.758, 0.864
Region
German speaking 1 1 1 1
French speaking 1.175 1.091, 1.266 1.147 1.071, 1.228 1.134 1.063, 1.208 1.133 1.063, 1.208
Italian speaking 1.190 1.026, 1.382 1.173 1.024, 1.344 1.236 1.086, 1.405 1.234 1.085, 1.403
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Figure 1: Conditional Distribution of BMI. For each combination of smoking and sex, the
conditional distribution of BMI P(BMI ≤ b | smoking, sex, x) corresponding to model (4) was
evaluated for baseline covariates x at all possible BMI values b. Red, female BMI distributions;
blue, male BMI distributions; solid lines, BMI distributions of active smokers; dashed lines,
never smoked; gray vertical lines, WHO categories 18.5, 25, 30. The model was fitted using
“exact” BMI values.
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Table 3: Estimated Non-proportional Odds Ratios for Smoking. Odds ratios comparing all
levels of smoking to the level never smoked for the events BMI ≤ 18.5, BMI ≤ 25, and
BMI ≤ 30 obtained from model (4) were fitted to “exact”BMI measurements; 95% confidence
Intervals are given.
BMI
Sex Smoking ≤ 18.5 ≤ 25 ≤ 30
Female Never 1 1 1
Former 0.993 0.794, 1.241 0.922 0.825, 1.031 0.987 0.823, 1.183
Light 1.462 1.135, 1.884 1.152 0.977, 1.358 1.638 1.187, 2.259
Medium 1.106 0.823, 1.488 0.975 0.830, 1.146 1.182 0.894, 1.564
Heavy 1.674 1.188, 2.358 0.925 0.756, 1.131 1.116 0.798, 1.562
Male Never 1 1 1
Former 0.457 0.193, 1.081 0.664 0.598, 0.737 0.757 0.649, 0.883
Light 0.727 0.275, 1.922 0.960 0.825, 1.117 1.226 0.926, 1.622
Medium 1.352 0.631, 2.900 1.059 0.917, 1.223 1.170 0.911, 1.503
Heavy 0.852 0.336, 2.161 0.832 0.721, 0.961 0.716 0.579, 0.885
the impact of sex of the individuals and smoking status on the continuous BMI distribution.
The model results were insensitive to BMI measurement scales or categorization schemes and
matched previously reported findings on the impact of smoking and sex of the individuals on
BMI. It was obvious from the conditional BMI distributions (Figure 1) that more restrictive
models, e.g., a conditional normal distribution with or without sex- and smoking-specific
variance (Sneve and Jorde 2008), would describe the BMI distributions less accurately. The
corresponding BMI-dependent odds ratios derived from continuous BMI logistic regression
(Table 3) also indicated that a model that assumed proportional and thus BMI-independent
odds would not be appropriate because odds ratios varied substantially as BMI cut-off points
increased.
We used a parsimonious approach in defining covariate parameters. We described the impact
of the covariates on the BMI distribution as being linear on the log-odds scale. We there-
fore assumed that the covariate parameters would be the same in all binary or polytomous
logistic regression models regardless of the ad hoc categorization applied. This corresponds
to the proportional odds assumption in polytomous logistic regression models. In principle,
this assumption could be relaxed by allowing BMI-dependent regression coefficients β(b), as
in multinomial regression. Similar outcome-varying parameters are called time-varying pa-
rameters in survival analysis and distribution regression in econometrics (Foresi and Peracchi
1995; Chernozhukov et al. 2013) and are a special case of conditional transformation models
(Hothorn et al. 2014). Whether the models for BMI can be improved by such an approach is
a matter of ongoing research.
From a practical point of view, one advantage of continuous outcome logistic regression is
the possibility of evaluating the likelihood of BMI values obtained at different measurement
scales or using different categorization schemes. This aspect allows the same model to be
fitted, and thus allows models from studies using different BMI measurement scales to be
compared. The narrower the interval representing the BMI value for a particular individual,
Lohse, Rohrmann, Faeh, Hothorn 13
the more information is contributed by this individual to the likelihood. In contrast to the
common procedure of downscaling all analyses by ad hoc categorization of BMI measurements
to the ubiquitous WHO categories (Flegal et al. 2013, 2014), we propose that a post hoc cat-
egorization of model parameters and contrasts. In subject-level meta analyses, the likelihood
contributions can be a mixture of exact, interval, or category-based BMI measurement scales.
The likelihood can also be extended to incorporate study-specific left and right truncation
when only individuals with BMI values in a pre-defined range are enrolled.
Our findings on the association between smoking and BMI are consistent with the results of
previous studies. It has been shown that former smoking is associated with being overweight
as well as obesity, especially for males (Chiolero et al. 2007; John et al. 2005; Mackay et al.
2013; Basterra-Gortari et al. 2010; Dare et al. 2015). Other studies have also observed a
positive association of male heavy smokers with obesity, although the association was non-
significant when male heavy smokers were compared with males who never smoked (Chiolero
et al. 2007; John et al. 2005). By contrast, light and moderate smoking was associated with
lower BMI values (Chiolero et al. 2007; John et al. 2005). In general, current smoking is
associated with lower BMI values (Albanes et al. 1987; Dare et al. 2015; Winslow et al. 2015).
These findings are consistent with previous findings on the effect of smoking on body weight
(Audrain-McGovern and Benowitz 2011; Chiolero et al. 2008).
Waiving the need for ad hoc categorization and thus also for agreement on standard categories
that define the parameters in models for BMI distributions makes reported scientific results
less dependent on these standard categories, and most importantly, less dependent on the
WHO criteria. Considering that BMI distributions are subject to change at the population
level over time (Ng et al. 2014), insistence on the application of standards defined decades
ago leads to an increasing discrepancy between models and data. Continuous BMI logistic
regression is an attempt to narrow this gap.
Online Appendix: Computational Details
The intercept functions α(b)smoking:sex for each combination of smoking and sex were esti-
mated as smooth and monotonically increasing functions of b. The constraints expit(r(∞ |
smoking, sex,x)) = 1 and expit(r(0 | smoking, sex,x)) = 0 restrict the BMI distribution on
the positive numbers. For each of the ten strata given by the five smoking categories and two
categories of sex, an intercept function was defined by six increasing parameters of a Bernstein
polynomial (Farouki 2012) of order five. This choice ensures smoothness and monotonicity
and allows flexible intercept functions and thus regression functions r and conditional BMI
distributions to be described by model (4). The monotonicity constrained on the intercept
functions renders the addition of smoothing penalty terms to the likelihood unnecessary, and
simple maximum-likelihood estimation was performed for all model parameters simultane-
ously. When the likelihood was evaluated for BMI values in WHO categories, the sex- and
smoking-specific intercept function was parameterized in terms of the step-function α(b) (see
Formula (3)) defined for the proportional odds model. All computations were performed us-
ing R version 3.3.3 (R Core Team 2015). The mlt package (Hothorn 2017, 2016) was used to
estimate continuous outcome logistic regression models. The underlying statistical theory is
described in Hothorn et al. (2016).
A blueprint for the estimation of conditional BMI logistic regression using the mlt package in
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R, assuming the data are available in a data frame sgb with variables bmi (the numeric BMI
values), smoking, and sex (smoking and sex as factors), as well as age and alcohol (numeric
age and alcohol intake) with optional sampling weights weights, is
### attach mlt package
library("mlt")
### compute support of BMI distribution
bmis <- quantile(sgb$bmi, prob = c(.01, .99), na.rm = TRUE)
vBMI <- numeric_var("bmi", bounds = c(0, Inf),
support = bmis, add = c(-5, 5))
### set-up increasing Bernstein polynomial
bBMI <- Bernstein_basis(vBMI, order = 5, ui = "increasing")
### set-up dummy encodings for smoking and sex
bSMK <- as.basis(~ smoking - 1, data = sgb)
bSEX <- as.basis(~ sex - 1, data = sgb)
### specify the model with strata sex and smoking and
### covariates age and alcohol
mod <- ctm(bBMI, interacting = b(sm = bSMK, sex = bSEX),
shifting = ~ age + alcohol, data = sgb,
todistr = "Logistic")
### fit model to data with weighted `exact' likelihood
fmod <- mlt(mod, data = sgb, scale = TRUE,
weights = sgb$weights)
### plot conditional BMI distribution for 18 year-old
### never-smoking non-drinking female
nsf18 <- data.frame(sex = factor(c("Female", "Male"))[1],
smoking = factor(c("Never", "Former", "Light", "Medium",
"Heavy"))[1],
age = 18, alcohol = 0)
plot(fmod, newdata = nsf18, type = "distribution")
Continuous outcome logistic regression, as a model for a continuous conditional distribution
implemented in mlt, has a very strong connection to the Cox proportional hazards model,
which describes the conditional continuous distribution of a survival time outcome with fully
parameterized log-cumulative hazard function (Hothorn et al. 2016; Hothorn 2016). A Cox
model for the conditional BMI distribution could be written as (Doksum and Gasko 1990)
cloglog(P(BMI ≤ b | smoking, sex,x)) = r(b | smoking, sex,x).
In this case, the logistic link in (1) was replaced by the complementary log-log link. In the
absence of covariates x, the results obtained from our continuous BMI logistic regression
model and a Cox model stratified by sex and smoking would not be affected by this change,
because for each combination of sex and smoking, a corresponding equivalent intercept func-
tion α(b)smoking:sex (the sex- and smoking-specific log-cumulative hazard in the stratified Cox
model) can be found on both the logit and cloglog scales. However, the interpretation of β
changes from proportional log-odds ratios to proportional log-hazard ratios. In contrast to
the partial likelihood of Cox models that treat the intercept functions as nuisance parameters,
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the likelihood for continuous outcome logistic regression is evaluated for fully parameterized
intercept functions and all model parameters are estimated by maximum likelihood (similar
to McLain and Ghosh 2013). The corresponding monotonicity constraint allows smooth con-
ditional distribution functions to be estimated without adding smoothing parameters to the
likelihood (Hothorn et al. 2016; Hothorn 2016).
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Background and aims: Type A behavior pattern (TABP) is a possible risk factor for cardiovascular disease
(CVD). However, existing evidence is conﬂicting, also because studies did not examine underlying traits
separately. In this study, we investigated whether all-cause and CVD mortality were associated with the
Bortner Scale, a measure of TABP, in particular with its subscales competitiveness and speed.
Methods: Information on Bortner Scale and covariates of 9921 participants was collected at baseline in
two cross-sectional studies that were linked with mortality information, yielding a follow-up of up to 37
years. We analyzed the Bortner Scale and its two subscales competitiveness and speed. Applying Cox
regression models, we investigated the association with all-cause, CVD, and speciﬁc CVD type mortality.
Results: During follow-up, 3469 deaths were observed (1118 CVD deaths). The total Bortner Scale was not
associated with mortality, only its subscales. In women, competitiveness was positively associated with
all-cause mortality (highest category vs. the lowest, HR 1.25 [95% CI 1.08,1.44]), CVD mortality (1.39
[1.07,1.81]), and ischemic heart disease mortality (intermediate category vs. the lowest, 1.46 [1.02,2.10]).
In men, CVD mortality was inversely associated with speed (highest category vs. the lowest, 0.74
[0.59,0.93]).
Conclusions: The subscales of the Bortner Scale may be associated with CVD in an opposed manner and
may therefore have to be analyzed separately. More studies are needed to further investigate this as-
sociation, also considering differences by sex. Persons scoring high in the competitiveness subscale ought
to be screened and counselled in order to reduce their CVD risk.
© 2017 Elsevier B.V. All rights reserved.
1. Introduction
The concept of Type A behavior pattern (TABP) was introduced
in the 1970s. Individuals having this trait are assumed to have a
higher risk for cardiovascular disease (CVD) [1]. TABP is deﬁned as
an action-emotion complex in which an individual's behavior is
characterized by ambitiousness, competitiveness, easily aroused
hostility, impatience and an exaggerated sense of time urgency [1].
Early investigations of the association between TABP and CVD
indicated a positive relationship with CVD incidence [2e6].
Furthermore, it was shown that the clinical outcome of CHD was
improved in patients undergoing behavioral counseling [7,8].
However, subsequent studies on CVD incidence [9e11] and mor-
tality [12e14] showed conﬂicting results. No associations of TABP
with cancer risk were observed [15,16].
Various instruments for measuring TABP were used to investi-
gate its association with health outcomes. As the concept of TABP
includes many different aspects of personality, it is a challenge to
capture it comprehensively. The Bortner Scale is a frequently used
instrument. Edwards et al. (1990) performed an exploratory factor
analysis and a subsequent conﬁrmatory analysis of dimensionality
to show that the Bortner Scale captures mainly two components of
TABP: competitiveness and speed [17]. The assignment of the
Bortner Scale items to these two subscales was driven by the aim to
maintain a simple structure and to enhance interpretability. In fact,
the subscales of the Bortner Scale may be differently associated
with morbidity and mortality and thus the effect estimates can be
underestimated towards the null, when analyzing the subscales
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only jointly. Hence, an analysis on subscale level is recommended
[17]. To our knowledge, other studies did not consider this
approach.
In this study, we investigated whether all-cause, CVD, CVD-
speciﬁc (i.e. ischemic heart disease and cerebrovascular disease),
and cancer mortality were associated with the Bortner Scale and its
two subscales competitiveness and speed.
2. Materials and methods
2.1. Study design, setting, and participants
We used data of two population-based Swiss studies, the ﬁrst of
three waves of MONICA (MONItoring of trends and determinants in
CArdiovscular disease) and the NRP1A (National Research Program
1A, community-based primary prevention of cardiovascular dis-
ease). In order to establish a mortality follow-up, the study cohorts
were linked with the Swiss National Cohort (SNC) using a record
linkage procedure. The study participants were aged !18 years at
baseline.
The ﬁrst wave of the MONICA study was conducted in 1983 and
was part of an international multicenter study initiated by the
World Health Organization [18]. The NRP1A study was conducted
from 1977 to 1979 [19]. In both studies, a self-administered ques-
tionnaire and a health examination were included at baseline. In-
formation on the cause of death was obtained through the SNC
using underlying cause of death from the national death registry
until 2014 [20,21]. The SNC is a national longitudinal research
platform linking census records with Federal death and migration
records covering all residents of Switzerland. Details about the
linkage process were reported elsewhere [20]. Successful linkage
was possible for 97% participants of the MONICA study and 94% of
the NRP1A study [21,22]. Approval for the SNC and the linkage with
MONICA and NRP1A was obtained from the Ethics Committee of
the Canton of Zurich (KEK Zurich, KEK-StV No. 13/06 and amend-
ment of June 12, 2008).
2.2. Variables
We used the Bortner Scale as a measure of TABP, consisting of 13
items. Compared with the original scale, the item „no outside in-
terests“ was not included. According to Edwards et al. (1990), we
built the two subscales of speed (9 items: never late, rushed,
impatient, goes all out, doing lots at once, forceful, wants job
recognized, fast, hide feelings) and competitiveness (3 items:
competitive, hard driving, ambitious) [17]. The Bortner Scale
additionally included the item “anticipate”. Each item ranges be-
tween 0 and 5, with 5 corresponding to TABP. Age, education,
marital status, nationality, language region, study, smoking status,
blood pressure, Body Mass Index (BMI), physical activity, and
alcohol consumption were considered as potential confounders.
Causes of death were coded according to the International
Classiﬁcation of Diseases (ICD; 8th revision until 1994,10th revision
since 1995). We investigated all-cause, CVD (ICD-8: 410e458, ICD-
10: I20-I99), CVD-speciﬁc (cerebrovascular diseases [ICD-8:
430e38, ICD-10: I60-69], ischemic heart disease [ICD-8: 410e414,
ICD-10: I20-25]), and total cancer (ICD-8140e209, 225, 230e239;
ICD-10: C00-C97, D32-D33, D37-D48) mortality.
2.3. Data sources and assessment
Data on the Bortner Scale and potential confounders were
assessed by self-administered questionnaires [18,19]. Height and
weight, which were used to calculate the covariate BMI and blood
pressure were measured at baseline [23].
2.4. Statistical methods
We pooled the data of MONICA and NRP1A as data collection on
the variables of interest was comparable. We added a variable
indicating the study, i.e. MONICA or NRP1A, to all models.
Cox regression was performed for all-cause, CVD, speciﬁc CVD
type (ischemic heart disease, cerebrovascular disease), and cancer
mortality. For the Cox regression, the Bortner Scale and its sub-
scales were categorized. Therefore, we built 3 groups by taking the
25th and the 75th percentile as cut-off points (total scale: "35, 36
to 44, !45, competitiveness subscale: "6, 7 to 9, !10, speed sub-
scale: "26, 27 to 33, !34). As sex differences were neglectable, we
used similar cut-off points for men andwomen. The 25th percentile
was used as reference category in the categorical model. A priori,
we decided to stratify by sex. Cox regression models were adjusted
for age, education, nationality, marital status, language region, and
study (MONICA wave 1, NRP1A) in the basic model as well as
smoking status, physical activity, alcohol consumption, BMI, and
blood pressure in the full model. Age was included as continuous
variable; education as the highest degree obtained and was cate-
gorized into mandatory, secondary, and tertiary. Nationality was
included as being Swiss or foreign. Marital status comprised of the
categories: single, married, widowed, and divorced/separated.
Language region reﬂects cultural differences within Switzerland
and the categories German/Romansh, French, and Italian were
taken into account. Smoking status was categorized into never,
former, light (1e9 cigarettes per day), moderate (10e19), and heavy
(>19). We categorized BMI (kg/m2) into underweight <18.5,
normal-weight !18.5 - <25, overweight !25 - <30, and obesity
!30 [24]. Physical activity during leisurewas included as sedentary,
moderate, and high. Alcohol consumption was categorized into
consumption yesterday yes or no. Observations withmissing values
on covariates were kept in the Cox regression by adding a missing
category to each variable.
In a sensitivity analysis, we investigated whether using a
competing-risks regression instead of a Cox regression model for
the CVD-speciﬁc mortality, i.e. ischemic heart disease and cere-
brovascular diseases, would have changed the results. Furthermore,
for statistically signiﬁcant associations observed in the Cox
regression analysis, we checked for interactions with lifestyle and
sociodemographic variables. All analyses were performed using
STATA 13.1, College Station, TX, USA.
3. Results
Our analyses included 4839 men and 5082 women (Table 1).
Men were more likely to be overweight or obese (50.3% vs. 29.8%),
smoker (44.4% vs. 26.2%), and having consumed alcohol yesterday
(71.3% vs. 41.4%); on the other hand they were more likely to have a
high level of physical activity during leisure (14.9% vs. 4.0%) and
being educated on a tertiary level (University, 7.7% vs. 2.1%). Hy-
pertension (BP! 140/90mmHg) was prevalent in 24.6% of men and
27.3% of women. Lifestyle and socioeconomic factors also differed
by TABP (data not shown). The more distinct TABP was, the less
likely were never smoking and physical activity. On the other hand
alcohol intake, being of foreign nationality and having a higher
educational degree was more likely in TABP prone individuals.
In total, 3469 deaths occurred, of which 1118 were due to CVD
and 1117 to cancer (Table 2); 464 deaths were caused by ischemic
heart disease and 229 by cerebrovascular diseases. Median survival
was 29.8 years.
The distribution of the Bortner Scale (median of 41) and of its
subscales competitiveness (median of 8) and speed (median of 30)
is shown in Fig. 1. We did not observe an association between total
Bortner Scale and mortality, but with its subscales (Table 2). A
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positive association of competitiveness with all-cause mortality
was observed in women (full model, comparing the highest cate-
gory with the lowest, HR 1.25 [95% CI 1.08,1.44]). Speed was
inversely associated with CVD mortality in men (0.74 [0.59,0.93]),
whereas competitiveness was positively associated with CVD
mortality in women (1.39 [1.07,1.81]).
Competitiveness was positively associated with ischemic heart
disease mortality in women (full model, comparing the interme-
diate category with the lowest, 1.46 [1.02,2.10]). The effect esti-
mates were about the same for the basic and the full model
(lifestyle factor adjusted).
The sensitivity analysis on competing risks for CVD speciﬁc
mortality led to similar results with regard to signiﬁcance for
ischemic heart disease (data not shown). In men, for cerebrovas-
cular diseases the non-signiﬁcant result of the Cox regression
became statistically signiﬁcant on the competitiveness subscale
(full model, comparing the highest category with the lowest, 1.87
[1.01,3.45]). Interactions of the subscales competitiveness and
speed with lifestyle variables were statistically non-signiﬁcant
(data not shown). For the association between all-cause mortality
and the competitiveness subscale, signiﬁcant interactions were
observed with sex (p ¼ 0.010) and education (p¼0.007); but not for
CVD mortality (data not shown).
4. Discussion
In our study, the Bortner Scale as a measure of TABP was not
associated with all-cause or cause-speciﬁc mortality. However,
several associations were found for its subscales such that,
competitiveness was positively associated with all-cause, CVD, and
ischemic heart disease mortality in women and speed was
inversely associated with CVD mortality in men. Adjusting for
lifestyle and clinical factors did not substantially change the results.
Studies on the association between health outcomes and TABP
as well as personality in general showed conﬂicting results.
Consistent with our null for the Bortner Scale, other studies also
showed no association between TABP and mortality. This was
observed for all-cause, CVD, and cancer mortality [9,14,25]. In
contrast to these studies, we separately analyzed the subscales
competitiveness and speed of the Bortner Scale. This approach
revealed the importance of competitiveness inwomen and speed in
men.
TABP and its associations with CVD as well as cancer incidence
were also investigated by others. While early investigations re-
ported positive associations for CVD outcomes [2e6], most studies
failed to reproduce these ﬁndings including a meta-analysis of
prospective studies on coronary heart disease [10,11,26e29]. Gal-
lacher et al. examined the role of length of follow-up and showed
that high scores of the Bortner Scale were associated with higher
risk for coronary heart disease events within the ﬁrst 5 years of
follow-up only. Based on this ﬁnding, the authors suggested that
TABP increases the exposure to potential triggers, i.e. circumstances
inducing extreme cardiovascular activity, and is not directly
affecting the process of atherosclerosis [30]. In line with our results,
cancer incidence was not associated with TABP [15].
Studies investigating personality traits in general observed for
all-cause mortality an association with conscientiousness only
[31e33]. For CVD mortality, there was evidence for a positive as-
sociation with neuroticism [12,34], anger, and hostility [35].
Furthermore, in a pooled analysis, a positive associationwas shown
between extraversion and stroke mortality as well as an inverse
association between conscientiousness and both coronary heart
disease and stroke mortality [12]. An earlier study by Nakaya et al.
did not show an association of personality with ischemic heart
disease or stroke deaths [36]. Although we did not ﬁnd an inter-
action between the subscales of the Bortner Scale and education for
CVD mortality, a growing body of evidence suggests that the as-
sociation between psychological factors and CVD risk might
depend on socioeconomic status [37,38]. In linewith our results, for
cancer incidence as well as mortality no association with person-
ality was observed [16,39].
Most of the studies reported their ﬁndings for men and women
combined. Only few studies restricting to males [6,10,26,27,33] or
females [32] presented sex-speciﬁc ﬁgures, however without
ﬁnding signiﬁcant associations. The sex-speciﬁc results in the
Table 1
Characteristics of the study population by sex (marital status and language region
not shown).a
Men Women
Age (y) 43.4 ± 13.7 43.7 ± 14.3
Survival (y) 27.3 ± 10.0 29.5 ± 8.8
Bortner Scaleb 40.8 ± 7.4 40.3 ± 7.2
Competitiveness subscaleb 8.3 ± 2.7 7.7 ± 2.5
Speed subscaleb 30.2 ± 5.6 30.3 ± 5.6
Total 4839 100.0 5082 100.0
Education
Tertiary 374 7.7 108 2.1
Secondary 3068 63.4 2838 55.8
Mandatory 1394 28.8 2133 42.0
Missing 3 0.1 3 0.1
Nationality
Swiss 3907 80.7 4298 84.6
Foreign 932 19.3 784 15.4
Studyc
MONICA I 1514 31.3 1393 27.4
NRP1A 3325 68.7 3689 72.6
Smokingd
Never 1509 31.2 3144 61.9
Former 1038 21.4 438 8.6
Light 575 11.9 415 8.2
Moderate 509 10.5 450 8.8
Heavy 1065 22.0 466 9.2
Missing 143 3.0 169 3.3
Physical activitye
Sedentary 1284 26.5 1494 29.4
Moderate 2777 57.4 3279 64.5
High 722 14.9 204 4.0
Missing 56 1.2 105 2.1
Alcohol intake, yesterday
Yes 3448 71.3 2103 41.4
No 1342 27.7 2906 57.2
Missing 49 1.0 73 1.4
BMI
Normal-weight 2363 48.8 3322 65.4
Underweight 39 0.8 240 4.7
Overweight 1977 40.9 1139 22.4
Obese 455 9.4 376 7.4
Missing 5 0.1 5 0.1
Blood pressuref
Normal, hypotension 1131 23.4 2112 41.6
Prehypertension 2503 51.8 2036 40.0
Grade 1 897 18.5 649 21.8
Grade 2 195 4.0 186 3.6
Grade 3 103 2.1 96 1.9
Missing 10 0.2 3 0.1
a Values are means ± SDs or n and %.
b Categorization: total scale: "35, 36 to 44, !45, competitiveness subscale: "6, 7
to 9, !10, speed subscale: "26, 27 to 33, !34.
c Study: MONICA (MONItoring of trends and determinants in CArdiovascular
disease), NRP1A (National Research Program 1A).
d Smoking: never, former, light (1e9 cigarettes per day), moderate (10e19), and
heavy (>19).
e Physical activity during leisure, including sports: sedentary (e.g. TV, reading),
moderate (e.g. walking, cycling, gardening), high (e.g. soccer, natation, rowing).
f Blood pressure: normal, hypotension (mean systolic <120 mmHg, mean dia-
stolic <80 mmHg), prehypertension (120e139 mmHg, 80e89 mmHg), Grade 1
(140e159 mmHg, 90e99 mmHg), Grade 2 (160e179 mmHg, 100e109 mmHg),
Grade 3 (>179 mmHg, >109 mmHg).
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Table 2
Association between mortality and Bortner Scale, and its subscales competitiveness and speed. HR (95% CI), statistically signiﬁcant results are highlighted in bold.
Mortality Basic modela Full modelb
1c,d 2 3 2 3
All-cause
Men cases, ne 529 848 526
Bortner Scale 1 0.97
(0.87; 1.08)
0.95
(0.84; 1.08)
0.97
(0.87; 1.09)
0.94
(0.83; 1.07)
Competitiveness 1 1.00
(0.90; 1.11)
0.95
(0.84; 1.08)
1.01
(0.91; 1.13)
0.96
(0.85; 1.09)
Speed 1 0.94
(0.85; 1.05)
0.94
(0.83; 1.07)
0.92
(0.83; 1.03)
0.90
(0.79; 1.02)
Women cases, n 463 736 367
Bortner Scale 1 0.98
(0.87; 1.11)
1.13
(0.98; 1.30)
1.02
(0.91; 1.15)
1.15
(1.00; 1.33)
Competitiveness 1 1.07
(0.96; 1.20)
1.26
(1.09;1.45)
1.08
(0.96; 1.21)
1.25
(1.08;1.44)
Speed 1 0.95
(0.85; 1.06)
1.05
(0.91; 1.20)
0.97
(0.87; 1.09)
1.05
(0.92; 1.21)
CVD
Men cases, n 205 274 152
Bortner Scale 1 0.87
(0.73; 1.05)
0.83
(0.67; 1.03)
0.89
(0.74; 1.07)
0.84
(0.68; 1.05)
Competitiveness 1 1.06
(0.88; 1.27)
0.90
(0.72; 1.12)
1.07
(0.89; 1.29)
0.92
(0.73; 1.15)
Speed 1 0.89
(0.75; 1.07)
0.77
(0.62;0.97)
0.86
(0.72; 1.03)
0.74
(0.59;0.93)
Women cases, n 161 236 90
Bortner Scale 1 1.05
(0.85; 1.28)
1.04
(0.80; 1.36)
1.14
(0.92; 1.40)
1.14
(0.86; 1.49)
Competitiveness 1 1.26
(1.04;1.54)
1.35
(1.04;1.75)
1.30
(1.06;1.59)
1.39
(1.07;1.81)
Speed 1 1.01
(0.83; 1.23)
1.01
(0.78; 1.31)
1.07
(0.88; 1.30)
1.06
(0.81; 1.38)
Ischemic heart disease
Men cases, n 100 129 75
Bortner Scale 1 0.82
(0.63; 1.07)
0.81
(0.60; 1.11)
0.84
(0.64; 1.10)
0.83
(0.61; 1.13)
Competitiveness 1 1.09
(0.84; 1.41)
0.77
(0.55; 1.08)
1.13
(0.87; 1.47)
0.81
(0.58; 1.14)
Speed 1 0.87
(0.67; 1.13)
0.85
(0.62; 1.17)
0.83
(0.64; 1.07)
0.82
(0.60; 1.13)
Women cases, n 53 80 27
Bortner Scale 1 1.03
(0.72; 1.47)
0.92
(0.57; 1.48)
1.14
(0.80; 1.64)
1.04
(0.64; 1.69)
Competitiveness 1 1.39
(0.97; 1.99)
1.46
(0.92; 2.33)
1.46
(1.02;2.10)
1.55
(0.97; 2.47)
Speed 1 0.75
(0.54; 1.06)
0.91
(0.59; 1.42)
0.81
(0.57; 1.14)
0.98
(0.63; 1.54)
Cerebrovascular diseases
Men cases, n 31 48 22
Bortner Scale 1 0.99
(0.63; 1.56)
0.79
(0.45; 1.38)
1.10
(0.69; 1.76)
0.89
(0.50; 1.60)
Competitiveness 1 1.35
(0.83; 2.21)
1.44
(0.82; 2.50)
1.45
(0.88; 2.37)
1.62
(0.92; 2.86)
Speed 1 1.03
(0.66; 1.62)
0.71
(0.38; 1.30)
1.05
(0.66; 1.65)
0.69
(0.37; 1.28)
Women cases, n 44 59 25
Bortner Scale 1 0.88
(0.59; 1.31)
0.93
(0.56; 1.54)
0.93
(0.62; 1.39)
1.01
(0.60; 1.69)
Competitiveness 1 1.20
(0.81; 1.76)
1.16
(0.69; 1.95)
1.26
(0.85; 1.87)
1.17
(0.70; 1.98)
Speed 1 1.22
(0.83; 1.79)
0.91
(0.53; 1.55)
1.26
(0.85; 1.86)
0.95
(0.56; 1.64)
Cancer
Men cases, n 155 301 183
Bortner Scale 1 1.12
(0.92; 1.37)
1.01
(0.81; 1.25)
1.12
(0.92; 1.36)
0.97
(0.78; 1.21)
Competitiveness 1 1.02
(0.84; 1.23)
0.99
(0.80; 1.23)
1.02
(0.84; 1.23)
0.99
(0.80; 1.23)
Speed 1 1.03
(0.85; 1.25)
0.96
(0.76; 1.19)
1.02
(0.84; 1.23)
0.90
(0.72; 1.12)
Women cases, n 130 216 132
Bortner Scale 1 0.93
(0.74; 1.16)
1.14
(0.89; 1.46)
0.96
(0.77; 1.20)
1.14
(0.89; 1.47)
T. Lohse et al. / Atherosclerosis 262 (2017) 19e2422
competitiveness subscale that we found might be partly explained
by a greater likelihood of CVD events induced by postmenopausal
hormone replacement therapy [40]. The inconsistent results for
TABP as well as personality in general might be due to different
exposure deﬁnitions and measurement instruments. In the context
of Type D personality (i.e. the general tendency towards emotional
distress characterized by high scores on social inhibition and
negative affectivity traits, and CVD events and mortality), Kupper
et al. found that selection of endpoint as well as age at baseline
changed the results [41].
Our study has several strengths and limitations. A broad range of
the Bortner Scale was observed in our study, and participants were
followed for up to 37 years with low loss to follow-up. In the
analysis, we took the subscales competitiveness and speed into
account. We showed that these subscales were associated with
mortality; whereas the total Bortner Scale was not. Furthermore,
we showed that the results stayed signiﬁcant after adjustment for
lifestyle factors, including blood pressure as a clinical factor. Data
on further potential adjustment variables like diabetes and prior
coronary artery disease was not available. We nevertheless believe
that these diseases are partially captured by measured blood
pressure. High blood pressure is strongly related with car-
diometabolic disorders. The health status of the participants in our
study was in terms of mortality better than in the general popu-
lation. Reasons for that may be health-interested participants' bias
and the fact that all participants had to personally attend a clinical
visit and thus to displace on their own. The Bortner Scale was
developed to measure TABP, but it has already been discussed by
others that it only comprises parts of TABP by measuring compet-
itiveness and speed [17]. As no other instruments collecting infor-
mation on TABP were available in our study, we investigated the
association of competitiveness and speed with mortality, instead of
speciﬁcally Type A behavior. Furthermore, we could not include
other personality traits in the analysis. In fact, the shown associa-
tion between CVD mortality and the competitiveness subscale in
women might have been modiﬁed or confounded by hostility
[35,42]. In the two study populations, the Bortner Scale was
assessed very similarly. Nevertheless, pooling could have intro-
duced bias, despite adjustment for study in all analyses. Moreover,
one has to consider that we investigated the association with
mortality and not with incident cases. Although having a long
follow-up, the number of CVD-speciﬁc deaths in the strata was
small and therefore the results have to be interpreted with caution.
Finally, we cannot exclude that some associations were due to
multiple testing.
We assume that the results of our analysis tend to underesti-
mate the real association between mortality and the Bortner Scale,
because as mentioned before, we expect our study population to be
healthier than the general population [43].
4.1. Conclusions
By considering the subscales competitiveness and speed of the
Bortner Scale, we showed their sex-speciﬁc association with all-
cause and CVD mortality. Future studies should also use this ana-
lytic approach to take into account the different dimensions of the
Bortner Scale and stratify by sex to allow for replication of the re-
sults. The subscales of the Bortner Scale may be associated with
CVD in an opposite manner. Competitiveness may increase the risk
particularly in women, whereas speed could be neutral or even
protective in men. Possibly, persons having the trait of competi-
tiveness should be considered as population with increased CVD
risk and be accordingly screened, counselled and treated.
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Fig. 1. Distribution of the Bortner Scale (n ¼ 9922, 0 to 65), speed subscale (n ¼ 10295,
0 to 15), competitiveness subscale (n ¼ 10275, 0 to 45), men and women combined.
Table 2 (continued )
Mortality Basic modela Full modelb
1c,d 2 3 2 3
Competitiveness 1 1.05
(0.85; 1.29)
1.23
(0.95; 1.59)
1.05
(0.85; 1.29)
1.20
(0.93; 1.56)
Speed 1 0.89
(0.72; 1.10)
1.00
(0.79; 1.28)
0.91
(0.74; 1.13)
0.99
(0.78; 1.27)
a Basic model adjusted for age, study, marital status, language region, education, and nationality.
b Full model additionally adjusted for smoking status, BMI category, physical activity, alcohol consumption, and systolic blood pressure.
c Reference category.
d Categorization: total scale: "35, 36 to 44, !45, competitiveness subscale: "6, 7 to 9, !10, speed subscale: "26, 27 to 33, !34.
e Cases (n) for the Bortner Scale, identical for the basic and the full model.
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